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Herein we report results from experiments aimed at better understanding SmI2(H2O)n reductions 
of allylic benzoates adjacent to a trisubstituted alkene. When flanked by both a chelating group 
and stereodirecting group, these reactions can occur with complete regioselectivity and good 
diastereoselectivity (up to 90:10). Initial experiments suggested that the reaction was 
stereospecific to alkene geometry. However, further experimentation has revealed that the alkene 
stereospecificity is substrate dependent. For instance, if the geminal alkene substituents are alkyl, 
results show the reaction to be stereospecific, but if one of the substituents is a phenyl group the 
reaction is still stereoselective but not stereospecific. This was demonstrated through the 
synthesis and subsequent SmI2(H2O)n reduction of a series of cis- and trans-allylic benzoate 
isomers followed by careful analysis of the product mixtures by 1H NMR. To explain these 
results our current working hypothesis is based on formation of an η3-organosamarium bicyclic 
intermediate. In some cases, C-C bond rotation in the pi-allyl intermediate relieves steric strain, 
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Chapter 1: Introduction 
 
1.1 The Importance of Stereocenters and Enantioselectivity.  
 
 The biological function of many organic molecules is strongly related to their three-
dimensional structure. Stereocenters comprised of a central carbon atom with four different 
substituents play an important role in dictating the three-dimensional shape of the organic 
molecules. By swapping two of the substituents, the three-dimensional space of the molecules is 
changed. Stereocenters are a key structural component, making up the sugars and proteins that 
create organic life and the way they interact with other molecules is intrinsically tied to their 
stereochemistry. 
 In the synthesis of pharmaceutical compounds stereochemistry is monitored 
meticulously. If stereochemistry is ignored, it could lead to drastic effects such as in the case of 
the over-the-counter drug Naproxen. Originally synthesized in 1970 by Harrison et al. they 
reported (S)-Naproxen (Figure 1) as the major enantiomer with anti-inflammatory activity.1 
Since then it has become widely known that the (R)-enantiomer holds little therapeutic effect and 
instead acts as a liver toxin. Contamination of the therapeutic (S)-Naproxen with (R)-Naproxen 
could cause needless liver injury, making the synthesis and isolation of (S)-Naproxen imperative. 
Many of the original syntheses of (S)-Naproxen involved making a 50:50 mixture of (S)-
Naproxen and (R)-Naproxen. These 50:50 mixtures of enantiomers are known as a racemate or a 
racemic mixture. The Naproxen racemic mixture is then resolved using cinchonidine or n-
alkylglucamine.2 Then as time progressed, enantioselective syntheses were introduced as they 





Figure 1. Structure of Naproxen enantiomers 
 
Another example of how important stereochemistry is in medicine is the drug 
Thalidomide (Figure 2). Thalidomide was prescribed as a racemate and seen as a relatively safe 
drug with no confirmed deaths from overdose even with an observed 14 gram overdose where 
the patient made a full recovery.4 Thalidomide was available for pregnant women as a treatment 
for morning sickness and recalled in 1961 after over 5000 cases of birth-defects were reported 
with pregnant women taking Thalidomide.5 It was later found by Blaschke et al. that the S-
enantiomer of Thalidomide was the teratogen responsible for the terrifying birth defects.6 
Blaschke et al. also supported the idea that (R)-Thalidomide was safe but later it would be 
determined that (R)-Thalidomide readily isomerizes to the (S)-isomer under biological 
conditions.7,8 After this catastrophe, the United States Food and Drug Administration introduced 
a new amendment that required drug manufacturers prove that their medicines were safe and 
effective at what they claimed.9   
 





1.2 Development of Samarium Di-Iodide Mediated Allylic Benzoate Reductions 
 
            In 1977, samarium diiodide was discovered as a novel reagent with synthetic utility for 
its reducing and coupling abilities.10,11 Since then, samarium diiodide has been found to have 
wide applications in enantioselective synthesis, in part due to the tunability of the reagent. With 
various additives such as hexamethylphosphoramide (HMPA), N,N′-dimethylpropyleneurea 
(DMPU), and alcohols the reduction potential, chemoselectivity, and rate of the reaction can be 
manipulated.12–15 Samarium diiodide is popular for its use in the Barbier and Reformatsky 
reactions as well as radical cyclization reactions,16,17 and has been used extensively in total 
synthesis.18–26 Samarium diiodide is also known for being less toxic and safer to use than other 
SET reagents such as tributyl tin hydride or sodium amalgam.27,28 
 In 2013, the O’Neil group began investigating samarium diiodide reductions of allylic 
benzoates. Specifically, they showed that aromatic allylic benzoates could be selectively 
eliminated and isomerized with samarium diiodide (SmI2) to form non-conjugated alkene 
products.29 The regioselectivity of SmI2 allylic benzoate reductions is rationalized through steric 
hindrance of a theorized organosamarium intermediate that undergoes a pericyclic protonation as 
seen in Scheme 1.  This work also showed that swapping the positions of the alkene and benzoyl 
group leads to the same products, suggesting that both converge to the same organo-samarium 









The O’Neil group saw the possible application of this reaction for the creation of a new 
stereocenter. If the starting material contained a tri-substituted alkene such as compound 1.1, 
then subsequent reduction with SmI2 would lead to a new stereocenter. Indeed, when treated with 
SmI2, compound 1.1 gave the expected product 1.2 containing a new stereocenter, however a 1:1 
mixture of diastereomers was obtained (Scheme 2).30 With this result it was theorized that 
introducing a chelating atom would facilitate facial preference of proton delivery from the 
proposed organosamarium intermediate.  




To test this idea, compound 1.3 was synthesized and its reduction with SmI2 was 
performed with various additives (Table 1).31 Results showed some enhancement in the 
diastereoselectivity (up to 69:31), supportive of this hypothesis, and okay regioselectivity (< 
5:1). It was hypothesized that the low chelating ability of the PMB-protected alcohol prevented 
higher d.r., consistent with a previous report from Keck and Wager who reported a loss in 
samarium chelation when reducing β-alkoxy ketones with a benzyl ether protecting group 




Table 1. Initial screening of 1.3 reduction with SmI2 in the presence of various additives. Adapted from reference.31 
 
 
Additivea Non-Conjugated:Conjugated  Non-conjugated d.r.b 
DMPU 1.3:1 60:40 
t-BuOH 3:1 69:31 
MeOH 3:1 60:40 
H2O 5:1 50:50 
Notes for Table 1: aReactions were performed by adding the additive (16 equiv. DMPU or 1400 equiv. ROH) to 
SmI2 (7 equiv.) followed by the substrate at room temperature. bDetermined by NMR.  
 




Analogous to Keck and Wager’s work, after the removal of the PMB protecting group 
and production of the free hydroxyl as a chelator, the O’Neil group was able to achieve complete 
regioselectivity (entries 2 and 5 in Table 2) and increase the d.r. up to 76:24 (Entries 5 and 7) for 
reductions of compound 1.4.31 Water as an additive gave the highest d.r. (76:24) and only made a 
nominal amount of the regioisomer. This was very desirable as water is readily available and 
non-toxic. In an attempt to improve the diastereoselectivity of the reaction further, the reaction 
was performed at 0 °C (Entry 6), however no significant change in d.r. was observed and there 





Table 2. Additive effects on SmI2 reductions of compound 1.4. Adapted from reference.31 
 
 
Entry Additivea 1.5 : 1.6b  1.5 d.r.b 
1. DMPU 2:1 75:25 
2. t-BuOH 1:0c 67:33 
3. i-PrOH 2.3:1 67:33 
4. MeOH 1:0c 60:40 
5. H2O 15:1 76:24 
6. H2Od 5:1 75:25 
 
Notes for Table 2: aReactions were performed by adding the additive (16 equiv. DMPU or 1400 equiv. ROH) to 
SmI2 (7 equiv.) followed by the substrate and stirring for 30 min. bDetermined by 1H NMR. c1.6 was not detected by 
NMR. dPerformed at 0 °C. eCompound 1.4 was used as a 1:1 mixture of diastereomers. 
 
Since the hypothesized intermediate involves loss of the benzoyl group, it was predicted 
that the stereochemistry of the benzoyl group was inconsequential to the final products. To be 
sure, a comparison of two differently enriched diastereomeric starting materials were tested 
(Figure 3).33 The results gave identical results, supporting the proposed mechanism (Scheme 4). 
As seen in the proposed mechanism, the formation of the allylic radical 1.4b eliminates 
stereochemistry at this position. The allylic radical formation of 1.4b is also thought to be the 





Figure 3. Effect of benzoyl stereochemistry on the stereoselectivity of SmI2(H2O)n reductions. Adapted from 
reference.33 
    
Scheme 4. Proposed mechanism of SmI2(H2O)n allylic benzoate reductions. Adapted from reference.33 
 
To determine the absolute stereochemistry of the new stereocenter formed from this 
reaction, compound 1.5 was subjected to ozonolysis to make 1.7 (Scheme 5).31 By comparing the 




enantiomer. This indicated that the main product of the reaction is the (2R,5R)-1.5, consistent 
with bicyclic intermediate 1.8 where the methyl group occupies a preferred pseudo-equatorial 
position.  




With evidence for a proposed 5-membered chelate, the question emerged how does 
chelate size affect diastereoselectivity in this reaction? To answer this question the O’Neil group 
synthesized a series of analogous compounds with differing linker lengths.30 The longest linker 
length would theoretically have a 7-membered chelate ring size. As shown in Table 3 (Entry 4), 
this less conformationally rigid substrate led to a lower d.r. and suffered from a variety of 
competing side reactions. Reducing the ring size down to a more rigid 6-membered chelate 
(Entry 3) gave comparable stereoselectivity as was previously seen for a 5-membered chelate 
(Entry 2). By shrinking the linker length even further (Entry 1) the O’Neil group was able to 
achieve the highest d.r. yet of 86:14, albeit with a decrease in yield due to competing β-
elimination of the hydroxyl forming a diene. Increasing equivalents of water increased the yield 





Table 3. Effects of linker length on diastereoselectivity. Adapted from reference.30 
 
 
Entry Starting Material Product d.r.a  
1. 1.9 1.12 (n=0) 86:14 
2. 1.4 1.5 (n=1) 76:24 
3. 1.10 1.13 (n=2) 78:22 
4. 1.11 1.14 (n=3) 63:37 
Notes for Table 3: aDetermined by NMR. 
 
 Within the five and six-membered chelate sizes it is also possible to move the 
stereodirecting methyl group along the carbon chain and see if it would play a role in 
diastereoselectivity. To probe this, a series of compounds were synthesized by the O’Neil group 
and reduced with SmI2 (Table 4).
30 The resulting reduced compounds were then subjected to 
ozonolysis to confirm stereochemistry. All results were consistent with formation of a bicyclic 
transition state with the stereodirecting methyl group in a preferred equatorial position. In 
general, the highest diastereoselectivities were observed when this methyl group was closest to 






Table 4. Comparison of methyl stereocenter position and the effect on regio- and diastereoselectivity for SmI2(H2O)n 
allylic benzoate reductions for substrates proceeding through 5- and 6-membered organosamarium chelates. 
Adapted from reference.30 
 
Entry Starting Material Product d.r.a Regioselectivitya 
1. 1.4 1.5 (x = 0, y = 1) 75:25 98:2 
2. 1.15 1.18 (x = 1, y = 0) 70:30 100:0 
3. 1.10 1.13 (x = 0, y = 2) 78:22 88:12 
4. 1.16 1.19 (x = 1, y = 1) 57:43b 94:6 
5. 1.17 1.20 (x = 2, y = 0) 56:44 83:17 
Notes for Table 4: All reactions were preformed using 105 equiv. of H2O and 7 equiv. of SmI2 in degassed THF at rt 
under N2. aDetermined by 1H NMR and GC-FID. bIdentical results were obtained when the reaction was performed 
under Ar. 
 
 As mentioned, all the results were consistent with an intermediate featuring an equatorial 
stereodirecting group. Increasing the steric demand of this stereodirecting group was therefore 
expected to lead to higher diastereoselectivity. To test this, another series of compounds were 
synthesized and reduced (Table 5). Increasing the steric bulk of the stereodirecting group from 
methyl to an isopropyl or benzyl group increased the d.r. of the reaction moderately, however 
this came at the cost of yield. Both phenyl and hydroxyl stereodirecting groups (Entries 4 and 6) 
suffered greatly from elimination, suggesting this position is sensitive to both acidic hydrogens 





Table 5. Stereodirecting group identity effects on regio- and diastereoselectivity for SmI2(H2O)n allylic benzoate 
reductions. Adapted from reference.30 
 
 
Entry R d.r.a Regioselectivitya Yield%b 
1. Me (1.4) 75:25 98:2 90 
2. i-Pr (1.21) 83:17 93:7 80 
3. t-Bu (1.22) 80:20 95:5 73 
4. Ph (1.23) 73:27 100:0 25 
5. Bn (1.24) 81:19 96:4 82 
6. OH (1.25) - - 0 
Notes for Table 5: Reductions were performed at room temp. using 7 equiv of SmI2 and 105 equiv of water. 
aDetermined by 1H NMR. bIsolated yield. 
Chapter 2 
 
2.1 Initial Diastereoselectivity Study  
 
With a better understanding of the parameters that effect diastereoselectivity in these 
reactions, the O’Neil group wanted to further explore and test their proposed mechanism. The 
proposed transition state suggests that switching the alkene geometry should also switch the 
configuration of the resulting stereocenter (i.e. the reaction should be stereospecific to alkene 
geometry). To test this, compounds 2.1 and 2.2 were synthesized as a partially separable mixture 
of cis- and trans-stereoisomers. Reduction of the differentially enriched samples gave the 
opposite diastereoselectivity, indicating that in this case the reaction was stereospecific to alkene 
geometry as predicted. (Scheme 6). These results further support formation of the proposed bi-
cyclic intermediate and a pericyclic protonation mechanism to illustrate how the reaction is 





Scheme 6. Alkene stereospecificity experiments using differentially enriched mixtures of 2.1 and 2.2. Colored lines 
are signals for the same colored hydrogens. Adapted from reference.33 
 
 
2.2 Comparing Different Chelate Sizes 
 
Previously, the O’Neil group had proposed two different samarium binding modes that 
were thought to be dependent on chelate size. The first of which can be seen in Scheme 7, where 
the proposed organosamarium species is shown using an η1 bonding mode as part of a 5,6-fused 
bicyclic transition state. The other proposed transition state uses an η3 bonding mode and can 
also be seen in Scheme 7. This intermediate was theorized for compounds with smaller linker 










To test if there were any effects of chelate size on stereospecificity, two more cis 
compounds were synthesized to compare to their trans counterparts. These pairs of cis/trans 
isomers were investigated featuring different hydroxyl group linker lengths that should 
theoretically control formation of an η1or η3 organosamarium intermediate. The synthesis of the 
cis compounds started with acetylide addition to aldehydes 2.4 or 2.8, derived from 
commercially available lactate and Roche esters, respectively (Scheme 8). An iron-catalyzed 
carbometalation of propargylic alcohols developed by Zhang and Ready was then performed on 
compounds 2.5 and 2.9.35 This procedure gave no reaction if allowed to warm above 0 ⁰C, likely 
be due to the decomposition of the iron catalyst to produce lower oxidation state species that are 
unreactive.36 However, at 0 ⁰C the reaction was sluggish, producing only small amounts (23-
30%) of the desired product that were inseparable from the starting material. Arguably, the 
propargylic position in our substrate is much more sterically hindered compared to the 
compounds presented by Zhang and Ready suggesting that this reaction could be sensitive to 
sterically hindered alkynes. Ultimately by using higher amounts of reagents, the cis-trisubstituted 
alkene 2.6 and 2.10 was obtained in 57 % and 53 % yield, respectively, albeit with small 




PMB group, cis compounds 2.7 and 2.11 were obtained in 56 % and 35 % yield, respectively for 
the two steps.  
Scheme 8. Synthesis of cis compounds 2.7 and 2.11. Reagents: i, n-BuLi, THF; ii, Fe(acac)3, dppe, MeMgBr, THF; 




Since the iron-catalyzed carbometallation produced an inseparable mixture of starting 
material and product, an alternative synthesis was investigated to reduce impurities. To do this, 
the previously made propargylic alcohols 2.5 and 2.9 were oxidized to their corresponding 
ynones using Dess-Martin periodinane (Scheme 9). Conjugate addition of a Gilman reagent to 
the α,β-ynones  2.12 and 2.14 gave tri-substituted alkenes 2.13 and 2.15 as an equal mixture of 
cis/trans isomers. These mixtures were reduced, benzoylated, deprotected, and purified by 
column chromatography on silica to yield partially separable mixtures of cis/trans isomers 2.15 





Scheme 9. Synthesis of cis compounds 2.7 and 2.11. Reagents: i, Dess-Martin Periodinane, NaHCO3, DCM; ii, 
MeLi, CuI, THF; iii, NaBH4;iv, MeOH BzCl, pyridine, DCM; v, DDQ, DCM, pH 7 buffer. 
 
 
Samarium reductions of compounds 2.7 and 2.11 were performed and the crude mixtures 
were analyzed by proton NMR. Comparison to results obtained from their trans isomers revealed 
that the reductions of these compounds was non-stereospecific to alkene geometry (i.e. the cis- 






Figure 4.  Reductions of cis substrates 2.7 and 2.11 compared to their trans counterparts show by NMR that these 
compounds are stereoselective under SmI2(H2O)n conditions.  
 
These results could be explained by rotation around the pi-allyl bond after formation of 
the organosamarium intermediate. For this to happen, the η3-complex would have to isomerize to 
an η1-complex Sm-2 (Scheme 10). Rotation could then occur around the carbon-carbon bond. 
Isomerization into the alternative η1 complex would then give an organosamarium intermediate 








This type of carbon-carbon bond rotation for  η3/η1 complexes has been observed for 
other organometallic intermediates.37–45 A few reported examples for palladium are shown in 
Scheme 11. During their characterization and analysis of allyl-palladium (aminoferrocenyl) 
phosphine ligands, Rafael Fernández-Galán et. al. observed two isomers M and m for the major 
and minor isomer, respectively (Scheme 11 B). It was determined that the palladium complex 
was isomerizing from the η3 complex to the η1 complex syn to phosphorus selectively. This 
selective isomerization has been observed with chiral ferrocene complexes46,47 and other 
heterobidentate palladium ligands.48,49 These examples caused Fernandez-Galan to postulate 
steric demand and the kinetic trans effect as the  origin of selective η1 isomerization. For our 
system, however, this η1 position is very sterically hindered, and it is hard to imagine how the 
organosamarium complex would form the octahedral or square planar geometry required for the 






Scheme 11. Examples of palladium η3- η1- η3 isomerizations. A) A chiral Lewis acid (LA*) imparts facial selectivity 
to the rapidly isomerizing palladium intermediate leading to enantioselectivity50. B) the formation of a selective σ-
allyl intermediate cis to phosphorus, rotation around the carbon-carbon bond, and reformation of the η3 complex 
explained the interconversion, and rotation observed with allyl-pladdium (Aminoferrocenyl)phosphine ligands37. C) 
Palladium when attached to the specialized “PNP” ligand  primarily sits in the η1 bonding mode but can isomerize 
the alkene geometry during η3- η1- η3 interconversions38.  
 
 
The η3 bonding mode has been recorded as the primary bonding mode for bis-
cyclopentadienyl samarium allyl complexes.51–53 Since the samarium bonding is largely ionic, 
the bonding mode will largely be controlled by sterics.54,55 Such was the case during Procter’s et. 
al. synthesis of δ-lactones where bulky SmCpR2 reagents showed evidence of η
1 bonding to allyl 
intermediates.56 Since the organosamarium intermediates produced from compounds 2.7 and 
2.11 have similar steric environments, and no discernable difference in stereospecificity, this 
could mean that both chelate sizes use the same η3 bonding mode. More specifically, reduction of 




Sm-6 which place the larger substituent (Ph) in a pseudo-axial position. Isomerization of these η3 
complexes to the corresponding η1 complexes would give Sm-5 and Sm-7, respectively. Rotation 
could then occur followed by isomerization into the energetically preferred η3 complexes Sm-8 
and Sm-9, allowing the cis- and trans- substrates to converge to the same organosamarium 
intermediate and ultimately the same major diastereomer product (Scheme 12).  
Scheme 12. Proposed rotation around the proposed bicyclic intermediate leading to the stereoselective reduction of 
2.7 and 2.11. 
 
 
2.3 Comparing n-Butyl vs Phenyl Substituents 
 
We hypothesized that if the steric difference between the two alkene substituents is small 
enough (e.g. for compounds 2.1 and 2.2) perhaps there is insufficient steric preference to cause a 
rotation around the pi allyl intermediate. To test this theory, three sets of cis/trans isomers 
containing methyl and n-butyl alkene substituents were synthesized and tested. The synthesis of 
the three trans isomers used zirconium-catalyzed carboalumination of n-hexyne followed by 




2.18) were acylated with benzoyl chloride and subsequently deprotected affording the desired 
trans substrates 2.17 and 2.19.  
Scheme 13. Synthesis of trans n-butyl compounds 2.23, 2.25, and 2.27. Reagents: i, AlMe3,Cp2ZrCl2; ii, BzCl, 
pyridine, DCM; iii, DDQ, DCM, pH 7 buffer; iv, p-TsOH, MeOH; v, TBSCl, imidazole, DCM.  
 
 
The cis isomers were all synthesized by starting with n-hexyne, forming the 
corresponding acetylide by deprotonation with n-BuLi, and addition to aldehyde 2.4 or 2.8 
(Scheme 14). The resulting secondary alcohols were subjected to iron-catalyzed carbometalation 
conditions to yield the cis alkenes 2.21 and 2.24. The less sterically demanding propargylic 
alcohols 2.20 and 2.23 reacted more readily to iron-catalyzed carbometallation conditions, 
resulting in complete consumption of starting material as determined by proton NMR analysis, 
supporting the theory that this chemistry is sensitive to sterically demanding alkynes. The 
resulting cis-alkene-containing secondary alcohols were then benzoylated and the PMB group 






Scheme 14. Synthesis of cis n-butyl compounds 2.30 and 2.33. Reagents: i, n-BuLi, THF; ii, Fe(acac)3, dppe, 





The three pairs of cis/trans butyl isomers were all reduced using 7 equivalents of SmI2 for 
all substrates, 100 equivalents of H2O for substrates 2.17 and 2.22, and 15 equivalents of H2O for 
substrates 2.19 and 2.25. The resulting product mixtures were analyzed by NMR to determine 
diastereoselectivity (Figure 5). Gratifyingly, these compounds containing sterically similar 





Figure 5. SmI2(H2O)n  reductions of butyl compounds are stereospecific with respect to alkene geometry. Notice the 
switching of major diastereomer in the spectra as alkene geometry is flipped from trans to cis. 
 
2.4 Bulky Alkyl Substituent 
 
With these results it was predicted that placing a large, sterically demanding alkyl group 
in place of the n-butyl group would in turn cause a loss in stereospecificity with respect to alkene 
geometry by inducing bond rotation upon formation of the organosmarium complex. To test this, 
a pair of cis/trans isomers were made where instead of an n-butyl group a cyclohexyl group 
would be introduced. To make these compounds similar methods were attempted. The synthesis 
of the trans substrate started with zirconium catalyzed hydroalumination of cyclohexyl acetylene 
followed by addition to aldehyde 2.8 to form the secondary alcohol 2.30 (Scheme 15). The 
secondary alcohol was then benzoylated and the crude product was treated with DDQ to remove 




steps. To synthesize the cis-isomer, cyclohexyl acetylene was deprotonated using n-BuLi to form 
the corresponding acetylide followed by the addition to the same aldehyde 2.8 to form the 
propargylic alcohol 2.32. This propargylic alcohol was then subjected to iron-catalyzed 
carbometallation. Unfortunately, even with increased equivalents of reagents and reaction time 
no reaction was observed. This result further supports our theory that sterically demanding 
alkynes are less reactive and sterically small substrates are optimal to these conditions. 
Scheme 15. Synthesis of sterically demanding cis/trans cyclohexyl/methyl substrates 2.31 and 2.35. Reagents: i, 
AlMe3,Cp2ZrCl2; ii, BzCl, pyridine, DCM; iii, DDQ, DCM, pH 7 buffer; iv, n-BuLi, THF; v, Fe(acac)3, dppe, 
MeMgBr, THF; vi, Dess-Martin Periodinane, NaHCO3, DCM; vii, MeLi, CuI, THF; viii, NaBH4, MeOH. 
   
 
To circumvent this result, our previous alternative synthesis was employed. This involved 
oxidizing the already made propargylic alcohol 2.32 to the corresponding ketone (2.33) with 
Dess-Martin periodinane. Conjugate addition of a Gilman reagent to the α,β-ynone 2.33 gave 
alkene 2.34 in 29% yield over the two steps as an equal mixture of cis/trans isomers. This 
mixture was reduced, benzoylated, deprotected, followed by purification by column 




Surprisingly, reduction of both isomers 2.31 and 2.35 (Figure 6) revealed that these 
substrates are stereospecific with respect to alkene geometry! Comparing cis/trans-isomers 1.4 
and 2.11 (for which the reaction was non-stereospecific) to isomers 2.31 and 2.35 (reaction is 
stereospecific), the only difference is a phenyl group vs. a cyclohexyl. Flowers had reported a 
drastic change in diastereoselective β-hydroxyketone reductions with a SmI2/H2O/Et3N mixture 
for substrates containing phenyl groups.57 Flowers postulated the electron deficient Sm3+ was 
interacting with the pi system of a nearby benzene ring leading to a different major diastereomer 
(Figure 7).  
 
Figure 6. SmI2(H2O)n  reductions of sterically demanding cyclohexyl/methyl compounds cis/trans isomers 2.31 and 
2.35 are also stereospecific with respect to alkene geometry. Whereas pure trans-2.31 gave a d.r. of 76:24 by 1H 





Figure 7. Depiction of possible intermediate leading to poor stereoselectivity or reversal of stereoselectivity when a 
phenyl group is α to the hydroxyl starting material. Adapted from Flowers et. al.57 
 
For our particular system, however, it is difficult to imagine a similar interaction that 
could lead to a loss in stereospecificity for these allylic benzoate reductions. From our previous 
work, we showed that the stereochemistry of the major product obtained from reduction of 
compound 1.4 was the 2R,5R-diastereomer (Scheme 5). This is consistent with a model wherein 
the phenyl group is not in close proximity to the bound samarium. Alternatively, for those 
substrates containing phenyl substituents, it may be that the η1 isomer Sm-5 and Sm-7 (ref. 
Scheme 12) wherein rotation can occur, has a greater contribution to the overall structure of the 
organosamarium intermediate. This could be rationalized by stabilization of the samarium-bound 
carbanion by the phenyl ring, or some type of interaction of the phenyl ring with samarium (an 
interesting reaction has been reported with Cp*2Sm(THF)2 and diazobenzene that forms an 
agostic bond to the ortho C-H bonds of the benzene58). While it has yet to be determined what 
exactly is causing this change in alkene stereospecificity, it appears nearby benzene rings can 





Figure 8. Potential agostic bond to the ortho C-H bond, stabilizing the η1 bonding mode, allowing free rotation, and 
leading to a loss in stereospecificity.  
 
In a computational study done by Solin and Szabó, they found that allyl η1 palladium 
complexes are destabilized by alkyl substitution at the metal-bonded carbon (Figure 9, 6b-d).59 
They also found that adding the electron withdrawing group -CF3 (9b-d) to the metal bonded 
carbon significantly stabilized the η1 complex when compared to the methyl substituted 
analogue. In a similar fashion, phenyl substituents in our substrates might act as resonance 
electron-withdrawing and stabilize the η1 organosamarium complex, allowing for rotation and a 
loss of stereospecificity. While on the other hand, alkyl substituents destabilize formation of the 
tertiary η1 complex, preventing rotation from occurring, and leading to a stereospecific reaction. 
Solin and Szabó also found that ligands can affect an η1  complex’s ability to rotate around the C-
C bond, as electron donating ligands allow for stronger hyperconjugative interactions between 
the dσ(Pd-C) and π
*(C=C) molecular orbitals. For our substrates with phenyl substituents 
however, the η1 samarium complex has two different π*(C=C) molecular orbitals that can be 
interacted with. One from the alkene moiety and the one from the benzene ring. This could 
possibly lower the energy barrier for C-C bond rotation as the dσ(Sm-C) molecular orbital can 
still be stabilized through hyperconjugative interactions with the phenyl’s π*(C=C) molecular 





Figure 9. Effects of monosubstitution of the allyl moiety (energies in kcal mol-1). All energies are zero-point energy-
corrected. For the sake of clarity, the hydrogens are represented by sticks. Figure from reference59 
 
Currently, there appears to be few mechanistic computational studies of samarium (II) 
reactions. Those that have been conducted include cyclopropanations,60,61 reductive 
cyclizations,62–65 and Barbier reactions.66 all of which are interesting and valuable to 
understanding the regio- and diastereoselectivity complex samarium-based reactions. For 
instance, Zhou and coworkers developed a samarium-catalyzed alkyne−azide cycloaddition that 
was thought to go through an unprecedented tandem anionic cascade cyclization and anti-
addition across the C≡C triple bond.67 To study this claim, Zhi-Ming et. al. studied several 
possible mechanistic pathways of these cylcoadditions.62 From this study they found how 
samarium influences the electrostatic potential of the starting materials which in turn affects 
regioselectivity, the most favored pathway in their study confirmed the proposed mechanism by 




Unfortunately, there appears to be a lack of information on samarium allyl-complexes of the type 
we have proposed.  Further study is needed to understand allyl samarium complexes and what 
properties control the stereospecificity of allylic benzoate reductions. Computation offers the 
potential to do so without excessive experimental testing.  
Chapter 3 
 
3.1 Tertiary Substrates – Preliminary Results 
 
Current results show cis- or trans-phenyl substituted substrates lead to the same major 
product in similar yields and diastereoselectivity. It is thought that this lack of alkene 
stereospecificity arises from an η1- η3- η1 isomerization of the organosamarium complex that 
allows for rotation and convergence which is promoted through stabilization by the phenyl ring. 
Previously we had shown that two different benzoyl ester isomers converge to the same 
organosamarium intermediate (ref. Scheme 1). This suggested that swapping the alkene and 
benzoate positions for substrates containing a phenyl substituent will have no effect on the 
diastereoselectivity of the reaction, as ultimately these compounds lead to the same intermediate. 
Combined with our experiments showing that benzoate stereochemistry has no effect on the 
resulting stereochemistry (Figure 3), this would mean that any of the 8 isomers in Scheme 16 









To test this theory, a tertiary benzoate isomer was synthesized as shown in Scheme 17. 
The synthesis started with an aldol addition of acetophenone to aldehyde 2.4 to form the β-
hydroxy ketone 3.1. The free hydroxyl was acylated with acetic anhydride and eliminated to 
form the α,β-enone 3.2 in 56% yield for the two steps. Methyl Grignard addition, acylation of the 
resulting alkoxide with benzoyl chloride, and deprotection of the secondary PMB-protected 
alcohol gave the tertiary benzoate substrate 3.3 in 25% yield (3-steps). 
Scheme 17. Synthesis of tertiary benzoate substrate 3.3. Reagents: i, LDA, THF, 2.4; ii, Ac2O, DMAP, DBU, THF; 
iii, MeMgBr, THF; iv, BzCl; v, DDQ, DCM, pH 7 buffer. 
 
 
As predicted, samarium reduction of the tertiary benzoate 3.3 gave identical results to 
compounds 1.9 and 2.7 (Figure 10). In future work, we plan to synthesize the cis isomer of the 






Figure 10. Reduction of structural isomer 3.3 results in the same major product as 2.15.  
 
Another future test involves making an n-butyl substituted (instead of phenyl) tertiary 
benzoate substrate, essentially “forcing” samarium to form an η1 complex where rotation is 
possible. This might lead to no diastereoselectivity, or at least lower than what was observed for 
compounds 2.17 and 2.22 (88:12 d.r.) since there is little steric differentiation between the 
methyl and n-butyl groups. On the other hand, a substrate containing a tertiary benzoate and a 
sterically demanding alkyl group (e.g. a cyclohexyl group) might be stereoselective in a similar 
fashion as the phenyl substrates. In this way, both compounds 2.31 and 3.4 would be expected to 
lead to the same major diastereomer (Scheme 18). 
Scheme 18. Predicted convergence of compounds 2.31 and 3.4 to the same major diastereomer due to the presence 








To summarize, the stereospecificity of samarium diiodide mediated allylic benzoate reductions 
appears to be sensitive to the electronics of the substrate. When one of the substituents is a 
benzene ring the reaction is non-stereospecific. Different phenyl-substituted alkene isomers 
converge to same major diastereomer, with the resulting stereochemistry arising from a bicyclic-
organosamarium intermediate that can rotate around the pi-allyl bond to place the benzene ring 
pseudo-equatorial. If the substituents are both alkyl, then the reaction is stereospecific to alkene 
geometry. It appears that regardless of steric demand, alkyl substituted substrates have restricted 
rotation and diastereoselectivity is controlled by the proposed bicyclic intermediate. This change 
in stereospecificity could be explained by the difference in the substrates ability to stabilize an η1 
intermediate that is required for C-C bond rotation and subsequently isomerization of alkene 
geometry. As stereospecificity does not appear to change with chelate size, it is likely that the 









General: All reactions were carried out under N2 in flame-dried glassware unless specified 
otherwise. The solvents used were dried by passing the solvent through a column of activated 
alumina under nitrogen immediately prior to use. All reagents were purchased and used as 
received unless otherwise mentioned. All TLC analysis used 0.25 mm silica layer fluorescence 
UV254 plates. Flash chromatography: SilaCycle silica gel P60 (230-400 mesh). IR: Nicolet iS10 
spectrometer, wavenumbers (~ ) in cm−1. NMR: Spectra were recorded on a Unity Inova 500 
MHz FT-NMR Spectometer in the solvents indicated; chemical shifts () are given in ppm, 
coupling constants (J) in Hz. Determination of diasteromeric ratios were calculated using 
MestreNova 10.0 software (example below). The solvent signals were used as references 
(CDCl3: C  77.00 ppm; residual CHCl3 in CDCl3: H  7.26 ppm).  
 
General Experimental Procedures 
Acetylide formation and addition to aldehydes: 
To a Schlenk tube filled with tetrahydrofuran (THF) (0.2 M relative to alkyne) and terminal 
alkyne (1.0 eq) at -78 ⁰C was added a solution of n-butyllithium (1.2 eq) dropwise and stirred for 
30 minutes. Aldehyde (0.8 eq) was then added dropwise and stirred at -78 ⁰C for one hour. The 
cold reaction mixture was poured to a seporatory flask containing saturated aq. ammonium 
chloride and extracted using ethyl acetate (3×). The combined organic extracts were dried over 




Iron-catalyzed carbometalation of propargylic alcohols: 
Methylmagnesium bromide (25 equiv) was added dropwise to a solution of iron(III) 
acetylacetonate (1.0 eq), 1,2-bis(diphenylphosphino)ethane (1.0 eq), alkyne (1.0 eq) and 
THF(0.08 M relative to alkyne) at -78 ⁰C. The resulting brown mixture was warmed to -20 ⁰C 
and stirred for seven hours at this temperature. After cooling to –78 ⁰C, the reaction was 
quenched slowly with isopropyl alcohol then saturated aq. Ammonium chloride, and extracted 
with ethyl acetate (3×). The combined organic extracts were dried over MgSO4, and concentrated 
in vacuo. 
Benzoylation of an alcohol: 
Pyridine (2 equiv.) was added to a Schlenk tube containing substrate (1 equiv.) in DCM (0.2 M 
relative to substrate). The mixture was then cooled to 0 oC followed by the addition of benzoyl 
chloride (1.2 equiv.). The reaction was allowed to warm to room temperature for 15 hours, 
quenched with aq. NaHCO3, and extracted with DCM (3x). The combined organic extracts were 
dried over MgSO4, and concentrated in vacuo. 
DDQ removal of PMB protecting group: 
The Substrate was added to a round bottom flask containing a 50:50 mixture of DCM:pH 7 
buffer (0.1 M relative to substrate). The reaction mixture was cooled to 0 oC and stirred 
vigorously at which time DDQ (3 equiv.) was added portionwise over 30 min. The reaction was 
left for 1 hour, quenched with aq. NaOH (1.0 M), extracted with DCM (3x). The combined 






SmI2 reductive elimination with H2O: 
To a dry Schlenk tube containing a solution of SmI2 in THF (0.1 M, 7 equiv.) was added 
degassed Nanopure H2O (105 equiv.) turning the solution a deep red color. The solution was 
stirred for 5 minutes and the substrate (1 equiv) was then added. After 30 minutes the reaction 
was quenched with aq. NaHCO3, and extracted with ethyl acetate (3x). The combined organic 
extracts were dried over MgSO4, and concentrated in vacuo. 
Zirconium catalyzed carboalumination: 
To a Schlenk tube filled with dichloromethane (DCM) (0.3 M relative to alkyne) and Cp2ZrCl2 
(0.1 eq) at -20 ⁰C was added trimethylaluminum (2.0 eq) dropwise resulting in a yellow solution 
which was stirred for 10 minutes. DI H2O (1.0 eq) was then added dropwise turning the solution 
a darker shade of yellow which was then stirred for another 10 minutes. The reaction was then 
warmed to room temperature for ten minutes and then cooled to 0 ⁰C. Phenylacetylene (1.0 eq) 
was added dropwise and the solution was stirred for 40 minutes at 0 ⁰C. Aldehyde (0.8 eq) was 
then added dropwise and the mixture stirred for 1 hour at 0 ⁰C. The reaction was quenched 
slowly with cold H2O and then aq. HCl (1 M), and extracted with DCM (3×). The combined 













Prepared according to the general procedure for iron-
catalyzed carbometalation of propargylic alcohols 
using propargylic alcohol 2.20 (0.100 g, 0.362 
mmol). Purification by flash column chromatography 
on silica gave 2.21 (0.082 g, 77 %) as a colorless oil.  
 
1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 
2H), 6.88 (d, J = 8.6 Hz, 2H), 5.23 – 5.16 (m, 1H), 
4.57 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1H), 
4.44 (dd, J = 8.8, 3.3 Hz, 1H), 3.80 (s, 3H), 3.52 (qd, 
J = 6.4, 3.3 Hz, 1H), 2.10 – 1.96 (m, 2H), 1.72 (d, J = 
1.4 Hz, 3H), 1.44 – 1.35 (m, 1H), 1.34 – 1.23 (m, 
3H), 1.13 (d, J = 6.4 Hz, 3H), 0.89 (t, J = 7.1 Hz, 
3H). 
 
13C NMR (126 MHz, CDCl3) δ 159.34, 140.91, 
130.82, 129.37, 123.58, 113.96, 77.48, 70.62, 70.09, 






Prepared according to the general benzoylation 
procedure using 2.21 (0.10 g, 0.35 mmol). The crude 
mixture was then subjected to the general procedure 
for removal of a PMB group with DDQ. Purification 
by flash column chromatography on silica gave 2.22 
(0.058 g, 61 % over two steps) as a colorless oil. 
 
IR (ATR): 3477, 2956, 2926, 2857, 1717, 1715, 
1700, 1696, 1694, 1684, 1601, 1585, 1457, 1451, 
1376, 1314, 1268, 1176, 1110, 1068, 1025, 997, 958, 
804, 709, 687 cm–1 
 
1H NMR (500 MHz, CDCl3) δ 8.05 (dt, J = 8.4, 1.7 
Hz, 2H), 7.56 (tt, J = 7.2, 1.2 Hz, 1H), 7.44 (t, J = 7.8 
Hz, 2H), 5.69 (dd, J = 9.5, 4.3 Hz, 1H), 5.32 (dd, J = 
9.3, 1.5 Hz, 1H), 4.00 (qd, J = 6.4, 4.2 Hz, 1H), 2.30 
(ddd, J = 13.4, 10.0, 5.3 Hz, 1H), 2.14 (ddd, J = 13.4, 
9.7, 5.7 Hz, 1H), 1.79 (d, J = 1.4 Hz, 3H), 1.52 – 1.29 
(m, 4H), 1.25 (d, J = 6.5 Hz, 3H), 0.90 (t, J = 7.1 Hz, 
3H). 
 
13C NMR (126 MHz, CDCl3) δ 166.02, 145.18, 
133.05, 130.51, 129.73, 128.44, 119.05, 75.44, 69.65, 
32.61, 30.55, 23.74, 22.91, 18.24, 14.08. 
 
 
(2R,5R,E)-5-methylnon-3-en-2-ol (2.27).  
 
Prepared according to the general procedure for 
SmI2(H2O)n reductions using 2.22 (0.0109 g, 0.0398 
mmol). Purification by flash column chromatography 
on silica gave 2.27 (0.0057 g, 92 %) as a colorless 
oil. 
 
Spectral data for the major of diastereomer. 
  
IR (ATR): 3380, 3066, 2917, 2859, 1633, 1593, 
1567, 1468, 1439, 1373, 1354, 1297, 1251, 1119, 
986, 935, 842, 780, 748, 729, 697, 654 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ 5.53 (dd, J = 15.4, 6.7 
Hz, 1H), 5.48 (dd, J = 15.4, 5.8 Hz, 1H), 5.48 (dq, J 
= 5.8ff, 2.5 Hz, 1H), 2.11 (dtq, J = 6.7, 6.4, 3.6 Hz, 
1H), 1.29 (m, 6H), 1.28 (d, J = 6.4, 3H), 1.00 (d, J = 
6.7 Hz, 3H), 0.91 (t, J = 7.1 Hz, 3H).  
 
13C NMR (126 MHz, CDCl3) δ 137.08, 132.29, 






Prepared according the general zirconium-catalyzed 
carboalumination using 1-hexyne (0.373 mL, 3.25 
mmol) and aldehyde 2.4 (0.500 g, 2.6 mmol). 
Purification by flash chromatography on silica gave 
2.16 (0.441 g, 58%), as a colorless oil and partially 
separable mixture of diastereomers (d.r = 56:44).  
Rf diastereomerα = 0.38; Rf diastereomerβ = 0.34 in 
4:1 Hex:EtoAc. 
 
Spectral data for diastereomer α:  
 
IR (ATR): 3420, 2980, 2928, 1614, 1570, 1265, 





1H NMR (CDCl3, 500 MHz): δ = 7.29 (d, J = 8.3 Hz, 
2H), 6.91 (d, J = 8.7 Hz, 2H), 5.13 (dq, J = 9.0, 1.3 
Hz, 1H), 4.64 (d, J = 11.4 Hz, 1H), 4.42 (d, J = 11.3 
Hz, 1H) 4.21 (dd, J = 9.0, 8.0 Hz, 1H), 3.82 (s, 3H), 
3.39 (dq, J = 8.0, 6.2 Hz, 1H), 2.04 (t, J = 7.7 Hz, 
2H), 1.71 (d, J = 1.4 Hz, 3H), 1.42 (m, 2H), 1.31 (h, J 
= 7.3 Hz, 2H), 1.13 (d, J = 6.2 Hz, 3H), 0.92 (t, J = 
7.3 Hz, 3H). 
13C NMR (CDCl3, 126 MHz): δ = 159.22, 141.64, 
130.31, 129.37, 123.08, 113.84, 78.91, 72.09, 70.80, 
55.20, 39.38, 29.79, 22.29, 16.97, 15.36, 13.92. 
 
Spectral data for diastereomer β:  
 
1H NMR (CDCl3, 500 MHz): δ = 7.27 (d, J = 8.7 Hz, 
2H), 6.88 (d, J = 8.7 Hz, 2H), 5.20 (dq, J = 8.5, 1.3 
Hz, 1H), 4.57 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.1 
Hz, 1H) 4.46 (dd, J = 8.3, 3.9 Hz, 1H), 3.81 (s, 3H), 
3.55 (qd, J = 6.4, 3.4 Hz, 1H), 2.01 (t, J = 7.0 Hz, 
2H), 1.64 (d, J = 1.4 Hz, 3H), 1.39 (p, J = 7.5 Hz, 
2H), 1.29 (m, 2H), 1.12 (d, J = 6.4 Hz, 3H), 0.89 (t, J 
= 7.3 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 159.17, 140.08, 
130.70, 129.20, 122.97, 113.81, 77.32, 70.50, 70.37, 
55.28, 39.39, 29.91, 22.34, 16.66, 14.17, 13.97. 
HRMS (ES+): m/z [315.1936]+ calcd for 






Prepared according to the general benzoylation 
procedure using 2.16 (0.431 g, 1.3 mmol). The crude 
mixture was then subjected to the general procedure 
for removal of a PMB group with DDQ. Purification 
by flash column chromatography on silica gave 2.17 
(0.344 g, 89 % over two steps) as an oil.  
 
Spectral data for the mixture of diastereomers: 
  
IR (ATR) 3462, 3062, 2956, 2929, 2871, 1714, 1600, 
1578, 1450, 1315, 1266, 1111, 1068, 962, 709 cm-1. 
 
1H NMR (CDCl3, 500 MHz): δ = 8.05 (dd, J = 8.5, 
1.3 Hz, 4H), 7.55 (t, J = 7.4 Hz, 2H), 7.44 (t, J = 7.7 
Hz, 4H), 5.66 (dd, J = 9.2, 4.4 Hz, 1H),  5.57 (dd, J = 
9.5, 7.2 Hz, 1H), 5.32 (dq, J = 9.2, 1.3 Hz, 1H),  5.20 
(dq, J = 9.5, 1.3 Hz, 1H), 4.03 (qd, J = 6.3, 4.2 Hz, 
1H), 3.97 (p, J = 6.6 Hz, 1H), 2.06 (t, J = 7.6 Hz, 
2H), 2.04 ( t, J = 7.3 Hz, 2H), 1.84 (d, J = 1.4 Hz, 
3H), 1.81 (d, J = 1.4 Hz, 3H)  1.40 (m, 4H), 1.29 (p, J 
= 7.4 Hz, 4H), 1.24 (d, J = 6.5 Hz, 3H), 1.22 (d, J = 
6.5 Hz, 3H), 0.89 (t, J = 7.3 Hz, 3H), 0.88 (t, J = 7.3 
Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 166.05, 165.96, 
144.48, 144.07, 132.97, 132.95, 130.44, 130.42, 
129.64, 129.63, 128.37, 119.36, 118.42, 76.80, 75.83, 
69.74, 69.54, 39.50, 39.46, 29.86, 29.80, 22.32, 
22.30, 18.73, 18.12, 17.20, 17.09, 13.94. 
HRMS (ES+): m/z [319.1310]+ calcd for 
C19H20O3Na+ [M+Na]+; found: 319.1314. 
 
 
(2R,5S,E)-5-methylnon-3-en-2-ol (2.26).  
 
Prepared according to the general procedure for 
SmI2(H2O)n reductions using 2.17 (0.030 g, 0.11 
mmol). Purification by flash column chromatography 
on silica gave the colorless oil 2.26 (0.010 g, 60 %) 
as a mixture of diastereomers (d.r. 90:10).  
 
Spectral data for the major diastereomer:  
 
IR (ATR) 3347, 2958, 2925, 2871, 2857, 1606, 1457, 
1371, 1258, 1150, 1123, 1060, 969, 730 cm-1. 
 
1H NMR (CDCl3, 500 MHz): δ = 5.54 (dd, J = 15.4, 
6.9 Hz, 1H), 5.48 (dd, J = 15.4, 6.0 Hz, 1H) 4.28 (p, J 
= 6.3 Hz, 1H), 2.11 (p, J = 6.6 Hz, 1H), 1.29 (m, 6H), 
1.28 (d, J = 6.3 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H), 
0.90 (t, J = 7.0 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 136.99, 132.24, 
69.03, 36.56, 36.14, 29.48, 23.49, 22.79, 20.40, 
14.08. 
 
HRMS (ES+): m/z [139.1487]+ calcd for C10H19 [M-






Prepared according to the general procedure for 
acetylide formation and attack of aldehyde using 
phenyl acetylene (0.10 mL, 1.03 mmol) and aldehyde 
2.4 (0.150 g, 0.77 mmol). Purification by flash 
chromatography on silica gave 2.5 (0.165 g, 72%), as 






Spectral data for the major of diastereomer. 
 
1H NMR (500 MHz, Chloroform-d) δ 7.47 (m, 2H), 
7.33 (td, J = 4.7, 3.0 Hz, 5H), 6.93 (m, 2H), 4.66 (d, J 
= 11.6 Hz, 1H), 4.55 (d, J = 11.5 Hz, 1H), 3.83 (s, 
3H), 3.78 (qd, J = 6.3, 3.7 Hz, 1H), 2.56 (d, J = 5.9 
Hz, 1H), 1.37 (d, J = 6.3 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ 159.33, 131.79, 
130.21, 129.42, 128.45, 128.26, 122.59, 113.91, 







Prepared according to the general procedure for iron-
catalyzed carbometalation of propargylic alcohols 
using propargylic alcohol 2.5 (0.100 g, 0.338 mmol). 
Purification by flash column chromatography on 
silica gave 2.6 (0.060 g, 57 %) as a yellow oil.  
 
Spectral data for the major diastereomer: 
 
1H NMR (500 MHz, Chloroform-d) δ 7.38 – 7.30 (m, 
5H), 7.25 – 7.19 (m, 3H), 6.94 – 6.85 (m, 3H), 5.56 
(dd, J = 9.3, 1.5 Hz, 1H), 4.47 (d, J = 11.6 Hz, 1H), 
4.37 (dd, J = 11.2, 1.6 Hz, 1H), 3.83 (s, 3H), 3.52 
(qd, J = 6.5, 3.4 Hz, 1H), 2.09 (d, J = 1.6 Hz, 3H), 






Prepared according to the general benzoylation 
procedure using 2.6 (0.060 g, 0.192 mmol). The 
crude mixture was then subjected to the general 
procedure for removal of a PMB group with DDQ. 
Purification by flash column chromatography on 
silica gave 2.7 (0.0317 g, 56 % over two steps) as an 
oil. 
 
Spectral data for major diastereomer. 
 
IR (ATR): 3455, 3057, 2974, 2926, 1718, 1715, 
1700, 1696, 1694, 1685, 1652, 1600, 1584, 1492, 
1457, 1451, 1375, 1314, 1266, 1177, 1109, 1069, 
1025, 997, 961, 916, 853, 904, 765, 709, 702, 668, 
667, 661, 655, 652 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J = 8.3, 1.4 
Hz, 2H), 7.57 (tt, J = 7.4, 1.3 Hz, 1H), 7.45 (t, J = 7.6 
Hz, 2H), 7.36 (tt, J = 7.7, 1.5 Hz, 2H), 7.31 – 7.27 
(m, 3H), 5.66 (dq, J = 9.6, 1.5 Hz, 1H), 5.42 (dd, J = 
9.6, 3.7 Hz, 1H), 3.99 (qd, J = 6.4, 3.7 Hz, 1H), 2.12 
(d, J = 1.5 Hz, 3H), 1.17 (d, J = 6.4 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ 165.29, 144.68, 
140.99, 133.16, 130.52, 129.82, 128.53, 127.66, 






Prepared according to the general procedure for 
zirconium-catalyzed carboaluminations using 
aldehyde 2.4 (0.500 g, 2.6 mmol). Purification by 
flash chromatography over silica gave the 
corresponding secondary alcohol (0.688 g, 82%, as a 
clear oil and partially separable mixture of 
diastereomers (d.r = 58:42).  
 
Rf diastereomerα = 0.30; Rf diastereomerβ = 0.20 in 
4:1 Hex:EtoAc. 
 
Spectral data for diastereomer α:  
 
IR (ATR): 3328, 3058, 3016, 2928, 1268, 1110, 932, 
711 cm–1. 
 
1H NMR (CDCl3, 500 MHz): δ = 7.40 (dd, J = 8.6, 
1.5 Hz, 2H), 7.33 (t, J = 7.1 Hz, 2H), 7.30 (d, J = 8.7 
Hz, 2H), 7.27 (t, J = 7.3, 1H) 6.90 (d, J = 8.7 Hz, 
2H), 5.70 (dq, J = 8.9, 1.4 Hz, 1H), 4.66 (d, J = 11.3 
Hz, 1H), 4.43 (d, J = 11.3 Hz 1H), 4.38 (dd, J = 8.9, 
7.7 Hz, 1H), 3.82 (s, 3H), 3.50 (dq, J = 7.7, 6.2 Hz, 
1H), 2.13 (d, J = 1.4 Hz, 3H), 1.20 (d, J = 6.2 Hz, 
3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 159.32, 142.98, 
139.81, 130.21, 129.48, 128.18, 127.30, 126.40, 
125.88, 113.92, 78.64, 72.44, 70.91, 55.26, 16.90, 
15.52. 
 
HRMS (ES+): m/z [335.1623]+ calcd for 
C20H24O3Na+ [M+Na]+; found: 335.1612. 
 





1H NMR (CDCl3, 500 MHz): δ = 7.40 (dd, J = 8.7, 
1.4, 2H), 7.32 (t, J = 7.19 Hz, 2H), 7.29 (d, J = 8.6 
Hz, 2H), 7.27 (t, J = 7.5 Hz, 1H), 6.89 (d, J = 8.7 Hz, 
2H), 5.80 (dq, J = 8.4, 1.3 Hz, 1H), 4.62 (dd, J = 8.4, 
3.6 Hz, 1H), 4.62 (d, J = 11.7, 1H), 4.50 (d, J = 11.7, 
1H), 3.81 (s, 3H), 3.66 (qd, J = 6.4, 3.5 Hz, 1H), 2.08 
(d, J = 1.4 Hz, 3H), 1.20 (d, J = 6.3 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 159.26, 143.03, 
138.24, 130.57, 129.53, 129.31, 128.23, 127.26, 
126.55, 125.89, 113.88, 77.19, 70.92, 70.62, 55.31, 
16.56, 14.42. 
 
HRMS (ES+): m/z [335.1623]+ calcd for 






Prepared according to the general benzoylation 
procedure using (2R,E)-2-((4-methoxybenzyl)oxy)-5-
phenylhex-4-en-3-ol (0.371 g, 1.18 mmol). The 
general procedure for DDQ removal of the PMB was 
then performed on the crude benzoylation product 
mixture obtained. Purification by flash 
chromatography on silica gave 1.9 (0.281 g, 80% 
over two steps) as an oil.  
 
Rf = 0.24 in 4:1 Hex:EtoAc. 
 
Spectral data for diastereomer α:  
 
IR (ATR) 3450, 3062, 3031, 2976, 2929, 1712, 1600, 
1583, 1450, 1266, 1110, 1025, 963, 909, 709 cm-1. 
 
1H NMR (CDCl3, 500 MHz): δ = 8.07 (dd, J = 8.3, 
1.2 Hz, 2H), 7.57 (t, J = 7.3 Hz, 1H), 7.45 (t, J = 8.1 
Hz, 2H), 7.41 (dd, J = 8.4, 1.5 Hz, 2H), 7.32 (t, J = 
7.1 Hz, 2H), 7.27 (t, J = 7.3 Hz, 1H), 5.77 (m, 2H), 
4.10 (p, J = 6.3 Hz, 1H), 2.29 (d, J = 1.2 Hz, 3H), 
1.30 (d, J = 6.4 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 166.01, 142.54, 
141.90, 133.09, 130.16, 129.66, 128.41, 128.27, 
127.68, 125.96, 122.37, 69.74, 18.81, 17.07. 
 
Spectral data for diastereomer β:  
 
1H NMR (CDCl3, 500 MHz): δ = 8.07 (dd, J = 8.3, 
1.2 Hz, 2H), 7.57 (t, J = 7.3 Hz, 1H), 7.45 (t, J = 8.1 
Hz, 2H), 7.43 (dd, J = 8.4, 1.3 Hz, 1H), 7.33 (t, J = 
7.1 Hz, 2H), 7.28 (t, J = 7.3 Hz, 1H), 5.91 (dq, J = 
9.3, 1.3 Hz, 1H), 5.85 (dd, J = 9.3, 4.0 Hz, 1H), 4.15 
(qd, J = 6.5, 4.1 Hz, 1H), 2.25 (d, J = 1.3 Hz, 3H), 
1.31 (d, J = 6.4 Hz, 3H).  
 
13C NMR (CDCl3, 126 MHz): δ = 165.94, 142.47, 
142.03, 133.06, 130.15, 129.64, 128.39, 128.25, 
127.66, 125.95, 122.37, 121.60, 76.73, 75.88, 69.59, 
18.19, 16.90. 
 
HRMS (ES+): m/z [319.1310]+ calcd for 





To a dry Schlenk tube containing a solution of SmI2 
in THF (0.1 M, 7.0 mL, 7 equiv.) was added 
degassed nano pure H2O (2.5 mL, 1400 equiv.) 
turning the solution a deep red color. The solution 
was stirred for 5 minutes before compound 1.9 (0.030 
g, 0.10 mmol) was then added. After 30 minutes the 
reaction was quenched with aq. NaHCO3 and 
extracted with EtOAc (3x). The combined organic 
extracts were dried over MgSO4, and concentrated in 
vacuo. Purification of the crude product mixture by 
flash chromatography on silica gave 1.12 (0.011 g, 
60%) as a mixture of diastereomers (d.r. 84:16).  
 
Rf = 0.30 in 4:1 Hex:EtoAc. 
 
Spectral data for the major diastereomer:  
 
IR (ATR) 3462, 3062, 2956, 2929, 2871, 1714, 1600, 
1578, 1450, 1315, 1266, 1111, 1068, 962, 709 cm-1. 
 
1H NMR (CDCl3, 500 MHz): δ = 7.30 (t, J = 7.6 Hz, 
2H), 7.22 – 7.18 (m, 3H), 5.82 (ddd, J = 15.4, 6.7, 1.1 
Hz, 1H), 5.56 (ddd, J = 15.5, 6.6, 1.4 Hz, 1H), 4.30 
(p, J = 6.4 Hz, 1H), 3.46 (p, J = 7.0, 6.4 Hz, 1H), 
1.36 (d, J = 7.0 Hz, 3H), 1.28 (d, J = 6.4 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 145.56, 135.41, 
132.87, 128.44, 127.16, 126.16, 68.87, 41.83, 23.42, 
21.17. 
 
HRMS (ES+): m/z [159.1174]+ calcd for C12H15 [M-








ol (2.23)  
 
Prepared according to the general procedure for 
acetylide formation and attack of aldehyde using 1-
hexyne (0.132 mL, 1.15 mmol) and aldehyde 2.8 
(0.200 g, 0.960 mmol). Purification by flash 
chromatography on silica gave 2.23 (0.183 g, 66%), 
as a clear yellow oil and a mixture of diastereomers 
(d.r = 72:28). 
 
Spectral data for major diastereomer. 
 
IR (ATR): 3434, 2957, 2932, 2871, 1612, 1586, 
1512, 1464, 1375, 1302, 1245, 1173, 1085, 1032, 
819, 754 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ 7.28 (td, J = 6.1, 2.6 
Hz, 2H), 6.90 (dd, J = 8.3, 1.6 Hz, 2H), 4.49 (d, J = 
11.3 Hz, 1H), 4.45 (d, J = 11.6 Hz, 1H), 4.43 – 4.38 
(m, 1H), 3.82 (s, 3H), 3.66 (dd, J = 9.3, 4.5 Hz, 1H), 
3.46 (dd, J = 9.3, 6.9 Hz, 1H), 3.06 (d, J = 5.0 Hz, 
OH), 2.23 (td, J = 7.0, 2.0 Hz, 2H), 2.05 (dqd, J = 
13.7, 6.9, 4.4 Hz, 1H), 1.53 – 1.46 (m, 2H), 1.43 (p, J 
= 7.1 Hz, 2H), 1.04 (d, J = 7.0 Hz, 3H), 0.93 (t, J = 
7.1 Hz, 3H).  
 
13C NMR (126 MHz, CDCl3) δ 159.30, 129.93, 
129.37, 113.83, 86.31, 79.00, 73.33, 73.17, 67.08, 




4-en-3-ol (2.24)  
 
Prepared according to the general procedure for iron-
catalyzed carbometalation of propargylic alcohols 
using propargylic alcohol 2.23 (0.183 g, 0.629 
mmol). Purification by flash column chromatography 
on silica gave 2.24 (0.072 g, 38 %) as a colorless oil. 
Spectral data for major diastereomer. 
 
1H NMR (500 MHz, CDCl3) δ = 7.28 (dd, J = 7.3, 1.6 
Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 5.24 (dd, J = 9.1, 
1.4 Hz, 1H), 4.51 – 4.43 (m, 3H), 3.83 (s, 3H), 3.51 
(dd, J = 9.8, 6.5 Hz, 1H), 3.43 (dd, J = 9.1, 5.2 Hz, 
1H), 2.09 (dd, J = 16.8, 8.3 Hz, 2H), 2.00 (tdd, J = 
7.0, 5.2, 3.9 Hz, 1H), 1.74 (d, J = 1.4 Hz, 3H), 1.54 – 
1.26 (m, 4H), 0.96 – 0.88 (m, 6H). 
 
13C NMR (126 MHz, CDCl3) δ = 159.26, 159.22, 
139.75, 139.58, 130.27, 130.06, 129.36, 129.30, 
129.26, 126.79, 125.48, 113.83, 113.79, 74.68, 73.44, 
73.04, 72.98, 72.37, 70.62, 55.28, 39.19, 39.18, 
32.04, 32.01, 30.51, 30.48, 23.59, 23.49, 22.83, 




benzoate (2.25)  
 
Prepared according to the general benzoylation 
procedure using 2.24 (0.072 g, 0.24 mmol). The 
crude mixture was then subjected to the general 
procedure for removal of a PMB group with DDQ. 
Purification by flash column chromatography on 
silica gave 2.25 (0.058 g, 69 % over two steps) as a 
colorless oil. 
 
Spectral data for major diastereomer. 
 
IR (ATR): 3432, 2958, 2930, 2872, 1714, 1601, 
1584, 1451, 1377, 1314, 1269, 1176, 1097, 1068, 
1025, 987, 908, 848, 804, 709, 686 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ = 8.06 (dt, J = 8.8, 1.7 
Hz, 2H), 7.58 (tt, J = 7.4, 1.3 Hz, 1H), 7.46 (t, J = 7.8 
Hz, 2H), 6.02 (dd, J = 9.1, 4.0 Hz, 1H), 5.43 (dd, J = 
9.1, 1.8 Hz, 1H), 3.67 – 3.42 (m, 2H), 2.46 (d, J = 7.3 
Hz, OH), 2.25 (ddd, J = 13.5, 9.4, 5.8 Hz, 1H), 2.15 
(ddd, J = 13.3, 9.3, 5.9 Hz, 1H), 2.04 (dddd, J = 13.3, 
8.8, 6.8, 2.9 Hz, 1H), 1.78 (d, J = 1.5 Hz, 3H), 1.48 – 
1.26 (m, 4H), 1.02 (d, J = 6.9 Hz, 3H), 0.91 (t, J = 7.2 
Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ 166.68, 142.37, 
132.99, 130.39, 129.68, 128.38, 121.50, 71.58, 64.66, 





Prepared according to the general procedure for 
SmI2(H2O)n reductions using 2.25 (0.023 g, 0.079 
mmol). Purification by flash column chromatography 
on silica gave 2.29 (0.010 g, 70 %) as a colorless oil. 
 
IR (ATR): 3339, 2956, 2923, 2871, 2856, 1456, 
1377, 1260, 1096, 1071, 1031, 968, 803, 728, 697, 
661 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ = 5.44 (ddd, J = 15.6, 
7.7, 1.1 Hz, 1H), 5.22 (ddd, J = 15.5, 7.9, 1.1 Hz, 




J = 10.5, 7.9, 3.2 Hz, 1H), 2.32 (dddd, J = 14.6, 7.9, 
5.5, 1.2 Hz, 1H), 2.11 (hept, J = 6.4 Hz, 1H), 1.39 
(dd, J = 8.0, 4.2 Hz, OH), 1.34 – 1.23 (m, 6H), 1.01 
(d, J = 6.9 Hz, 3H), 0.99 (d, J = 6.9 Hz, 3H), 0.91 (t, 
J = 6.9 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 138.74, 130.19, 





4-en-3-ol  (2.18)  
 
Prepared according the general zirconium-catalyzed 
carboalumination using 1-hexyne (0.069 mL, 0.60 
mmol) and aldehyde 2.8 (0.100 g, 0.48 mmol). 
Purification by flash chromatography on silica gave 
2.18 (0.058 g, 39%), as a colorless oil and partially 
separable mixture of diastereomers (d.r = 86:14).  
Spectral data for major diastereomer. 
 
IR (ATR): 3439, 2957, 2928, 2857, 1669, 1612, 
1586, 1512, 1456, 1442, 1373, 1361, 1301, 1245, 
1172, 1089, 1034, 1009, 819, 756, 708 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ = 7.28 (d, J = 8.6 Hz, 
2H), 6.90 (d, J = 8.5 Hz, 2H), 5.18 (dq, J = 9.1, 1.4 
Hz, 1H), 4.48 (s, 2H), 4.30 (td, J = 8.4, 1.0 Hz, 1H), 
3.83 (s, 3H), 3.58 (dd, J = 9.3, 4.5 Hz, 1H), 3.48 (dd, 
J = 9.3, 7.7 Hz, 1H), 3.16 (d, J = 2.5 Hz, 1H), 2.03 
(p, J = 7.7 Hz, 2H), 1.91 (hd, J = 7.2, 4.4 Hz, 1H), 
1.68 (d, J = 1.4 Hz, 3H), 1.41 (hd, J = 7.5, 2.2 Hz, 
2H), 1.31 (h, J = 7.2 Hz, 2H), 0.92 (t, J = 7.2 Hz, 
3H), 0.83 (d, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 159.27, 139.21, 
130.04, 129.32, 126.15, 113.84, 74.76, 73.06, 72.78, 





benzoate (2.19)  
 
Prepared according to the general benzoylation 
procedure using 2.18 (0.058 g, 0.19 mmol). The 
crude mixture was then subjected to the general 
procedure for removal of a PMB group with DDQ. 
Purification by flash column chromatography on 
silica gave 2.19 (0.034 g, 61 % over two steps) as a 
colorless oil. 
 
IR (ATR): 3435, 2957, 2928, 2872, 2859, 1714, 
1601, 1584, 1491, 1451, 1382, 1315, 1269, 1176, 
1098, 1069, 1025, 987, 949, 932, 852, 805, 732, 709, 
687 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ = 8.06 (dd, J = 8.3, 1.4 
Hz, 2H), 7.58 (tt, J = 7.5, 1.3 Hz, 1H), 7.46 (t, J = 7.8 
Hz, 2H), 5.78 (dd, J = 9.4, 8.3 Hz, 1H), 5.29 (dq, J = 
9.4, 1.3 Hz, 1H), 3.64 (dd, J = 11.4, 4.5 Hz, 1H), 3.60 
(dd, J = 11.4, 4.5 Hz, 1H), 2.07 (tt, J = 7.1, 1.0 Hz, 
2H), 2.02 (pt, J = 8.3, 7.0, 4.5 Hz, 1H), 1.80 (d, J = 
1.3 Hz, 3H), 1.43 (dddd, J = 11.0, 9.3, 5.2, 2.4 Hz, 
2H), 1.31 (dddd, J = 15.8, 14.4, 7.3, 1.8 Hz, 2H), 
1.05 (d, J = 7.0 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 166.55, 142.68, 
132.96, 130.88, 129.67, 128.01, 121.31, 73.35, 64.25, 





Prepared according to the general procedure for 
SmI2(H2O)n reductions using 2.19 (0.034 g, 0.12 
mmol). Purification by flash column chromatography 
on silica gave 2.28 (0.014 g, 71 %) as a colorless oil. 
 
IR (ATR): 3339, 2957, 2924, 2871, 2858, 1457, 
1377, 1033, 968 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ = 5.43 (ddd, J = 15.5, 
7.7, 1.1 Hz, 1H), 5.21 (ddd, J = 15.4, 7.9, 1.2 Hz, 
1H), 3.50 (ddd, J = 10.4, 8.0, 5.5 Hz, 1H), 3.37 (ddd, 
J = 10.5, 7.9, 4.2 Hz, 1H), 2.32 (tddd, J = 7.9, 6.7, 
5.5, 1.1 Hz, 1H), 2.10 (h, J = 6.7 Hz, 1H), 1.39 (dd, J 
= 8.1, 4.3 Hz, 1H), 1.35 – 1.21 (m, 6H), 1.00 (t, J = 
6.8 Hz, 6H), 0.90 (t, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 138.70, 130.21, 










IR (ATR): 3406, 2961, 2909, 2860, 1735, 1612, 
1512, 1489, 1463, 1443, 1302, 1245, 1173, 1082, 
1030, 911, 818, 756, 733, 791, 667 cm–1. 
 
Prepared according to the general procedure for 
acetylide formation and attack of aldehyde using 
phenyl acetylene (0.13 mL, 1.15 mmol) and aldehyde 
2.8 (0.200 g, 0.96 mmol). Purification by flash 
chromatography on silica gave 2.9 (0.228 g, 77%), as 
a clear yellow oil and a mixture of diastereomers (d.r 
= 55:45). 
 
Spectral data for mixture of diastereomers: 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.44 – 7.40 
(m, 4H), 7.35 – 7.29 (m, 10H), 6.88 (t, J = 8.5 Hz, 
4H), 4.70 – 4.62 (m, 2H), 4.55 – 4.47 (m, 4H), 3.81 
(s, 3H), 3.79 (s, 3H), 3.77 (dq, J = 7.1, 2.4, 1.9 Hz, 
2H), 3.57 (dd, J = 9.1, 4.3 Hz, 1H), 3.52 (dd, J = 9.3, 
6.8 Hz, 1H), 3.25 (dd, J = 5.6, 1.9 Hz, 1H), 2.43 – 
2.34 (m, 1H), 2.19 (hd, J = 6.9, 4.2 Hz, 1H), 1.14 (d, 
J = 7.0 Hz, 3H), 1.00 (d, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 131.75, 131.73, 
129.43, 129.32, 128.28, 128.25, 128.23, 113.88, 
113.86, 73.35, 73.31, 73.29, 73.14, 67.51, 66.99, 







Prepared according to the general procedure for iron-
catalyzed carbometalation of propargylic alcohols 
using propargylic alcohol 2.9 (0.125 g, 0.402 mmol). 
Purification by flash column chromatography on 
silica gave 2.10 (0.069 g, 53 %) as a yellow oil. 
Spectral data for major diastereomer: 
 
IR (ATR): 3425, 2907, 1729, 1617, 1611, 1586, 
1512, 1493, 1463, 1442, 1361, 1302, 1245, 1173, 
1076, 1033, 910, 818, 765, 729, 701, 668 cm–1. 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.37 – 7.33 
(m, 2H), 7.30 – 7.25 (m, 3H), 7.25 – 7.22 (m, 2H), 
6.93 – 6.85 (m, 2H), 5.50 (dq, J = 9.7, 1.5 Hz, 1H), 
4.43 (d, J = 8.3 Hz, 2H), 3.98 (dd, J = 9.6, 8.0 Hz, 
1H), 3.82 (s, 3H), 3.53 (dd, J = 9.3, 4.3 Hz, 1H), 3.38 
(dd, J = 9.3, 8.0 Hz, 1H), 2.09 (d, J = 1.5 Hz, 3H), 
1.92 (dddd, J = 12.4, 7.9, 4.9, 2.7 Hz, 1H), 0.78 (d, J 
= 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 159.28, 141.51, 
140.32, 129.86, 129.40, 129.33, 129.30, 129.26, 
128.68, 128.24, 128.21, 128.18, 128.16, 127.90, 
127.84, 127.18, 126.88, 126.85, 113.87, 113.83, 
113.80, 74.99, 73.84, 73.04, 72.95, 55.28, 39.05, 






IR (ATR): 3398, 3061, 2693, 2924, 1718, 1716, 
1700, 1696, 1692, 1685, 1652, 1601, 1584, 1557, 
1539, 1506, 1492, 1457, 1451, 1374, 1314, 1269, 
1176, 1110, 1069, 1025, 912, 805, 765, 742, 700, 
685, 668, 652 cm–1. 
 
Prepared according to the general benzoylation 
procedure using 2.10 (0.0693 g, 0.212 mmol). The 
general procedure for DDQ removal of the PMB was 
then performed on the crude benzoylation product 
mixture obtained. Purification by flash 
chromatography on silica gave 1.9 (0.0233 g, 35% 
over two steps) as an oil.  
 
Spectral data for mixture of diastereomers: 
 
1H NMR (500 MHz, Chloroform-d) δ = 8.13 (dd, J = 
8.4, 1.3 Hz, 2H), 8.05 (ddd, J = 14.0, 8.4, 1.4 Hz, 
2H), 7.66 – 7.55 (m, 2H), 7.52 – 7.43 (m, 6H), 7.40 – 
7.35 (m, 4H), 7.28 (m, 4H), 5.74 (d, J = 2.1 Hz, 2H), 
5.63 (dq, J = 9.6, 1.4 Hz, 2H), 5.52 (dd, J = 9.6, 7.7 
Hz, 2H), 3.49 (t, J = 4.6 Hz, 2H), 3.46 (dd, J = 11.6, 
5.7 Hz, 1H), 3.39 (dd, J = 11.6, 8.1 Hz, 1H), 2.13 (d, 
J = 1.5 Hz, 3H), 2.13 (d, J = 0.7 Hz, 3H), 2.06 – 1.93 
(m, 2H), 1.00 (dd, J = 7.0, 3.8 Hz, 6H). 
 
13C NMR (126 MHz, CDCl3) δ = 166.24, 143.00, 
142.06, 140.93, 133.69, 133.02, 130.37, 130.19, 
129.72, 129.68, 129.53, 129.01, 128.51, 128.47, 
128.43, 128.39, 128.37, 128.27, 127.61, 127.49, 
127.47, 127.35, 127.32, 123.85, 123.59, 74.11, 72.79, 






Prepared according to the general zirconium-




g, 4.7 mmol). Purification by flash chromatography 
on silica gave (2S,E)-1-((4-methoxybenzyl)oxy)-2-
methyl-5-phenylhex-4-en-3-ol (1.31 g, 85%) as a 
colorless oil.  
Rf = 0.65 in 1:1 hexanes:EtOAc. 
 
IR (ATR): 3320, 3028, 2986, 2962, 2851, 1713, 
1611, 1595, 1576, 1440, 1246, 1035, 699 cm–1. 
 
1H NMR (CDCl3, 500 MHz): δ = 7.43 (d, J = 7.1 Hz, 
2H), 7.34 (t, J = 7.3 Hz, 2H), 7.29 (t, J = 8.7 Hz 3H),  
6.91 (d, J = 8.6 Hz, 2H), 5.78 (dq, J = 8.9, 1.4 Hz, 
1H), 4.50 (d, J = 11.7, 1H), 4.51 (m, 1H), 4.47 (d, J = 
11.7Hz, 1H), 3.83 (s, 3H), 3.66 (dd, J = 9.3, 4.3 Hz, 
1H), 3.51 (dd, J = 9.3, 7.6 Hz, 1H), 2.12 (d, J = 1.4 
Hz, 3H), 2.03 (qd, J = 7.4, 4.3 Hz, 1H). 0.93 (d, J = 
7.1 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 159.27, 143.22, 
137.42, 129.87, 129.50, 129.34, 128.15, 127.10, 
125.88, 113.84, 74.49, 73.11, 73.10, 55.25, 39.34, 
16.52, 13.45. 
 
HRMS (ES+): m/z [349.1780]+ calcd for 




benzoate (1.4).  
 
Prepared according to the general procedure for 
removal of a PMB group with DDQ using (2S,E)-1-
((4-methoxybenzyl)oxy)-2-methyl-5-phenylhex-4-en-
3-ol (1.2 g, 2.78 mmol). Purification by flash 
chromatography on silica gave 1.4 (0.6 g, 70%) as an 
oil.  
 
Rf = 0.18 in 4:1 hexanes:EtOAc. 
 
IR (ATR): 3420, 3060, 3032, 2964, 2922, 2880, 
1714, 1450, 1268, 1110, 932, 711 cm–1. 
 
1H NMR (CDCl3, 500 MHz): δ = 8.07 (dd, J = 8.3, 
1.2 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.7 
Hz, 2H), 7.42 (dd, J = 7.2, 1.3 Hz, 2H), 7.33 (t, J = 
7.7 Hz, 2H), 7.28 (t, J = 7.2 Hz, 1H), 5.95 (dd, J = 
9.4, 8.1 Hz, 1H), 5.84 (dq, J = 9.4, 1.4 Hz, 1H), 3.68 
(qd, J = 11.3, 4.6 Hz, 2H), 2.23 (d, J = 1.4 Hz, 3H), 
2.15 (m, 1H), 1.10 (d, J = 7.0 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 166.48, 142.73, 
140.69, 133.05, 130.20, 129.67, 128.38, 128.25, 
127.54, 125.96, 124.33, 73.31, 64.09, 40.55, 16.88, 
12.92. 
 
HRMS (ES+): m/z [333.1467]+ calcd for 
C21H26O2Na+ [M+Na]+; found: 333.1472. 
 
 
(2R,5R,E)-2-methyl-5-phenylhex-3-en-1-ol (1.5)  
 
Prepared according to the general procedure for 
SmI2(H2O)n reductions using compound 1.4 (0.025 g, 
0.08 mmol). Purification of the crude product mixture 
by flash chromatography on silica gave 1.5 (0.0135 g, 
90%) as an oil.  
 
Rf = 0.31 in 4:1 hexanes:EtOAc. 
 
IR (ATR): 3360, 3083, 3061, 3025, 2961, 2925, 
2871, 1950, 1876, 1803, 1716, 1601, 1492, 1415, 
1373, 1272, 1029, 971, 760, 698 cm–1. 
 
1H NMR (CDCl3, 500 MHz): δ = 7.38 (t, J = 4.7 Hz, 
1H), 7.30 (t, J=6.9 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 
5.74 (ddd, J = 15.5, 6.8, 1.1 Hz, 1H), 5.33 (ddd, J = 
15.5, 7.9, 1.4 Hz, 1H), 3.47(m, 2H), 3.38 (dd, J 
=10.6, 8.1, 1H)  2.36 (hept, J = 7.0 Hz, 1H), 1.36 (d, 
J = 7.0 Hz, 3H), 1.01 (d, J = 6.9 Hz, 3H). 
 
13C NMR (CDCl3, 126 MHz): δ = 146.04, 136.89, 
131.00, 128.43, 127.07, 126.06, 67.35, 42.27, 39.66, 
21.48, 16.60. 
 
HRMS (ES+): m/z [190.1358]+ calcd for C13H18O+ 




methylpent-1-yn-3-one (2.33).  
 
Prepared according to the general procedure for 
acetylide formation and attack of aldehyde using 
cyclohexyl acetylene (0.110 mL, 0.842 mmol) and 
aldehyde 2.8 (0.153 g, 0.926 mmol). The crude oil 
product was then dissolved in 4 mL of DCM and the 
flask was placed into a room temp water bath. To the 
flask, sodium bicarbonate (353 mg, 4.2 mmol) and 
Dess-Martin periodinane ( 537 mg, 1.27 mmol) was 
added. The solution was stirred at room temp for 1 
hour. The reaction was washed with 1M NaOH 




combined organic extracts were dried over MgSO4, 
and concentrated in vacuo. Purification by flash 
chromatography on silica gave 2.33 (0.123 g, 47%), 
as an oil. 
 
IR (ATR): 2931, 2854, 2203, 1669, 1611, 1511, 
1449, 1300, 1245, 1172, 1089, 1032, 943, 918, 819, 
743 cm–1 
 
1H NMR (500 MHz, CDCl3) δ = 7.28 – 7.25 (m, 2H), 
6.92 – 6.87 (m, 2H), 4.47 (s, 2H), 3.83 (s, 3H), 3.76 
(dd, J = 9.3, 6.8 Hz, 1H), 3.56 (dd, J = 9.3, 5.7 Hz, 
1H), 2.87 (h, J = 6.8 Hz, OH), 2.57 (tt, J = 9.1, 3.9 
Hz, 1H), 1.87 – 1.80 (m, 2H), 1.76 – 1.68 (m, 2H), 
1.52 (dtt, J = 12.2, 8.7, 3.2 Hz, 3H), 1.42 – 1.32 (m, J 
= 3.7 Hz, 3H), 1.21 (d, J = 7.1 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 190.13, 159.20, 
130.22, 129.27, 113.74, 99.02, 79.69, 72.88, 71.14, 




methylhex-4-en-3-one (2.34).  
 
A Schlenk tube was charged with copper (I) iodide 
(0.112 g, 0.588 mmol) and THF (2 mL). The solution 
was cooled to -30 oC and a 1.6M solution of MeLi in 
ether was added dropwise. After stirring for 30 
minutes at -30 oC the solution was cooled to -78 oC 
and 2.33 (0.123 g, 0.392 mmol) was added dropwise 
turning the solution yellow. The reaction was left for 
1 hour at -78 oC, quenched with saturated aq. NH4Cl 
(5 mL) and separated with DCM (3 x 5 mL). ). The 
combined organic extracts were dried over MgSO4 
and concentrated in vacuo. Purification by flash 
chromatography on silica gave the oil 2.34 (0.079 g, 
61%), as a 50:50 cis/trans mixture. 
 
Spectral data for the cis isomer: 
 
IR (ATR): 2926, 2851, 1738, 1679, 1608, 1511, 
1448, 1370, 1301, 1244, 1171, 1093, 1033, 915, 892, 
819, 771, 757, 732 cm–1 
 
1H NMR (500 MHz, CDCl3) δ = 7.25 (dd, J = 8.7, 2.3 
Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 6.12 (t, J = 1.2 Hz, 
1H), 4.47 (d, J = 11.7 Hz, 1H), 4.43 (d, J = 11.7 Hz, 
1H), 3.82 (s, 3H), 3.68 (dd, J = 9.3, 7.3 Hz, 1H), 3.43 
(ddd, J = 9.2, 6.1, 3.0 Hz, 1H) 2.86 (m, J = 6.4 Hz, 
1H), 2.13 (d, J = 1.2 Hz, 3H), 1.98 (tt, J = 11.3, 3.4 
Hz, 1H), 1.79 – 1.67 (m, 4H), 1.45 – 1.13 (m, 
6H),1.11 (d, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 203.28, 202.34, 
164.95, 164.24, 159.13, 130.47, 129.33, 129.21, 
122.92, 121.06, 113.80, 113.72, 72.87, 72.85, 72.09, 
72.04, 55.27, 49.06, 47.56, 47.46, 40.54, 31.41, 
30.95, 30.91, 26.43, 26.24, 26.22, 26.12, 21.21, 





yl benzoate (2.35) 
 
The ketone 2.34 (0.607 g, 0.184 mmol) was dissolved 
with methanol (1 mL) in an open air flask. Sodium 
borohydride was added to the stirring mixture. The 
reaction was left for 1 hour at room temperature, 
quenched with saturated aq. NH4Cl (5 mL) and 
separated with ethyl acetate (3 x 5 mL). ). The 
combined organic extracts were dried over MgSO4, 
and concentrated in vacuo. The crude reaction 
mixture was then subjected to the general 
benzoylation procedure and subsequently the general 
procedure for removal of a PMB group with DDQ. 
Purification by flash column chromatography on 
silica gave a partially separable mixture of cis/trans 
isomers 2.50 (0.052 g, 42 % over three steps) as a 
colorless oil. 
 
Spectral data for the major diastereomer of the cis-
isomer: 
 
IR (ATR): 3427, 2925, 2852, 1711, 1602, 1584, 
1513, 1450, 1378, 1314, 1272, 1176, 1113, 1097, 
1069, 1025, 985, 906, 847, 731, 710, 687 cm–1 
 
1H NMR (500 MHz, CDCl3) δ = 8.07 (ddd, J = 8.5, 
2.4, 1.3 Hz, 2H), 7.63 – 7.53 (m, 1H), 7.46 (t, J = 7.8 
Hz, 2H), 6.08 (dd, J = 8.9, 4.2 Hz, 1H), 5.34 (dq, J = 
9.0, 1.5 Hz, 1H), 3.52 (t, J = 7.9, 5.9 Hz, 1H), 3.50 
(dd, J = 7.9, 4.6 Hz, 1H), 2.60 (tq, J = 11.1, 3.2 Hz, 
1H), 2.43 (dd, J = 8.2, 5.0 Hz, 1H), 2.04 (m, 1H), 
1.79 (m, 1H), 1.71 (d, J = 1.5 Hz, 3H), 1.72 – 1.67 
(m, 1H), 1.60 – 1.49 (m, 2H), 1.41 – 1.26 (m, 4H), 
1.20 – 1.12 (m, 2H), 1.02 (d, J = 6.9 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 166.62, 166.48, 
147.49, 146.66, 132.97, 132.94, 130.47, 130.43, 
129.67, 128.37, 121.21, 120.81, 72.26, 71.15, 64.68, 
64.14, 41.16, 40.60, 40.40, 31.11, 30.99, 30.94, 










Prepared according to the general procedure for 
SmI2(H2O)n reductions using compound 2.35 (0.0068 
g, 0.021 mmol). Purification of the crude product 
mixture by flash chromatography on silica gave 2.37 
(0.0034 g, 81 %) as an oil.  
 
IR (ATR): 3335, 2957, 2922, 2851, 2360, 2342, 
1448, 1373, 1032, 989, 969, 678, 668 cm–1 
 
1H NMR (500 MHz, CDCl3) δ = 5.46 (ddd, J = 15.3, 
8.2, 0.7 Hz, 1H), 5.19 (ddd, J = 15.4, 8.0, 0.7 Hz, 
1H), 3.50 (dt, J = 11.1, 6.0 Hz, 1H), 3.37 (t, J = 9.3 
Hz, 1H), 2.33 (heptq, J = 6.7, 1.1 Hz, 1H), 1.96 (h, J 
= 6.9 Hz, 1H), 1.77 – 1.62 (m, 4H), 1.38 (OH, 1H), 
1.28 (s, 1H), 1.22 (tq, J = 12.7, 3.2 Hz, 2H), 1.15 (dt, 
J = 11.3, 2.5 Hz, 2H), 1.01 (d, J = 6.8 Hz, 3H), 0.98 
(dd, J = 6.8, 0.7 Hz, 3H), 0.93 (ddd, J = 12.0, 8.4, 4.0 
Hz, 2H). 
 
13C NMR (126 MHz, CDCl3) δ = 137.28, 130.98, 







Prepared according to the general zirconium-
catalyzed carboalumination using cyclohexyl 
acetylene (0.078 mL, 0.60 mmol) and aldehyde 2.8 
(0.100 g, 0.480 mmol). Purification by flash 
chromatography on silica gave 2.30 (0.116 g, 35%) 
as a colorless oil.  
 
IR (ATR): 3444, 2924,  2851, 1611, 1586, 1512, 
1448, 1420, 1362, 1301, 1246, 1172, 1082, 1034, 
1004, 908, 846, 819, 730 cm–1. 
 
1H NMR (500 MHz, CDCl3) δ = 7.30 – 7.26 (m, 2H), 
6.90 (d, J = 8.6 Hz, 2H), 5.17 (d, J = 9.0 Hz, 1H), 
4.48 (s, 2H), 4.31 (t, J = 8.3 Hz, 1H), 3.83 (s, 3H), 
3.58 (dd, J = 9.2, 4.5 Hz, 1H), 3.47 (dd, J = 9.3, 7.6 
Hz, 1H), 1.94 – 1.83 (m, 2H), 1.81 – 1.73 (m, 2H), 
1.73 – 1.67 (m, 2H), 1.66 (d, J = 1.3 Hz, 3H), 1.28 
(dddt, J = 19.9, 16.5, 7.5, 3.9 Hz, 3H), 1.18 (tdd, J = 
14.3, 6.1, 2.5 Hz, 3H), 0.83 (d, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 159.40, 144.17, 
129.45, 124.59, 113.97, 74.85, 73.18, 72.78, 55.42, 





yl benzoate (2.31) 
 
Prepared according to the general benzoylation 
procedure using 2.30 (0.116 g, 0.349 mmol). The 
general procedure for DDQ removal of the PMB was 
then performed on the crude benzoylation product 
mixture obtained. Purification by flash 
chromatography on silica gave 2.31 (0.024 g, 21% 
over two steps) as an oil.  
 
IR (ATR): 3434, 2924, 2852, 1714, 1601, 1584, 
1491, 1449, 1375, 1314, 1269, 1216, 1175, 1111, 
1097, 1069, 1036, 1025, 987, 934, 892, 847, 805, 
777, 737, 709, 686 cm–1 
 
1H NMR (500 MHz, CDCl3) δ = 8.06 (dd, J = 8.5, 1.5 
Hz, 2H), 7.59 (m, 1H), 7.46 (t, J = 7.7 Hz, 2H), 5.79 
(dd, J = 9.4, 8.4 Hz, 1H), 5.29 (dt, J = 9.4, 1.3 Hz, 
1H), 3.64 (dd, J = 11.3, 4.4 Hz, 1H), 3.61 (d, J = 12.0 
Hz, 1H), 2.03  (m, 1H), 1.92 (ddd, J = 13.7, 10.8, 2.6 
Hz, 1H), 1.79 (d, J = 1.4 Hz, 3H), 1.76 (d, J = 2.6 Hz, 
2H), 1.74 – 1.66 (m, 2H), 1.35 – 1.11 (m, 6H), 1.04 
(d, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 166.57, 132.96, 
129.69, 128.37, 119.65, 73.31, 64.24, 47.43, 40.55, 






Prepared according to the general procedure for 
SmI2(H2O)n reductions using compound 2.31 (0.0068 
g, 0.0214 mmol). Purification of the crude product 
mixture by flash chromatography on silica gave 2.36 
(0.0034 g, 81 %) as an oil.  
 
IR (ATR): 3331, 2957, 2921, 2850, 1448, 1371, 
1030, 989, 969, 965, 889 cm–1 
 
1H NMR (500 MHz, CDCl3) δ = 5.45 (ddd, J = 15.4, 
8.3, 1.0 Hz, 1H), 5.19 (ddd, J = 15.4, 8.0, 1.0 Hz, 




10.4, 8.0 Hz, 1H), 2.34 (pp, J = 6.7, 1.2 Hz, 1H), 1.96 
(h, J = 6.8 Hz, 1H), 1.77 – 1.63 (m, 4H), 1.40 (m, 
1H), 1.27 – 1.08 (m, 4H), 1.01 (d, J = 6.8 Hz, 3H), 
0.98 (d, J = 6.9 Hz, 3H), 0.97 – 0.87 (m, 2H). 
 
13C NMR (126 MHz, CDCl3) δ = 137.09, 130.91, 







To a dried Sclenck flask, dry THF (3.2 mL) and 
diisopropyl amine (0.203 mL, 1.45 mmol) were 
added under nitrogen. The mixture was cooled to -78 
oC and an n-BuLi solution (0.463 mL, 2.5M) was 
added dropwise. The solution was then transferred to 
an ice water bath and allowed to stir for 10 minutes. 
The mixture was then cooled to -78 oC and 
acetophenone (0.116g, 0.965 mmol) was added 
dropwise. The reaction mixture was allowed to stir 
for 1 hour at -78 oC. Then the aldehyde 2.4 (0.138 g, 
0.772 mmol) was added dropwise and the reaction 
mixture was allowed to stir for another hour at -78 
oC, quenched with saturated aq. NH4Cl (5 mL) and 
separated with DCM (3 x 5 mL). The combined 
organic extracts were dried over MgSO4 and 
concentrated in vacuo. Purification by flash 
chromatography on silica gave the oil 3.1 (0.108 g, 
48 %), as a 50:50 cis/trans mixture. 
Spectral data for the major diastereomer 
 
IR (ATR): 3059, 2974, 2932, 2863, 2836, 1735, 
1676, 1670, 1652, 1636, 1623, 1613, 1597, 1579, 
1512, 1464, 1447, 1353, 1302, 1244, 1208, 1173, 
1147, 1079, 1032, 1011, 976, 820, 774, 755, 696, 
667, 661 cm–1. 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.95 (dt, J = 
8.4, 1.2 Hz, 2H), 7.61 – 7.55 (m, 1H), 7.47 (td, J = 
7.8, 7.4, 1.5 Hz, 2H), 7.30 – 7.25 (m, 2H), 6.88 (t, J = 
8.5 Hz, 2H), 4.63 (d, J = 11.4 Hz, 1H), 4.41 (d, J = 
11.4 Hz, 1H), 4.28 – 4.23 (m, 1H), 3.81 (s, 3H), 3.64 
(qd, J = 6.3, 4.4 Hz, 1H), 3.16 (d, J = 5.2 Hz, 1H), 
1.30 (d, J = 6.3 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 200.12, 159.26, 
137.00, 133.34, 130.49, 129.49, 128.61, 128.21, 







IR (ATR): 2974, 1931, 2936, 1676, 1670, 1669, 
1622, 1613, 1597, 1512, 1505, 1448, 1324, 1302, 
1279, 1267, 1245, 1207, 1172, 1147, 1076, 1031, 
1012, 977, 845, 820, 773, 755, 731, 695, 667, 662 
cm–1. 
 
To a dried flask containing THF (3.2 mL) and 3.1 
(0.0483 g, 0.159 mmol), DMAP (0.175 g, 1.43 
mmol) and acetic anhydride (0.150 mL, 1.59 mmol) 
was added at 0 oC. The mixture was then allowed to 
warm to room temperature and stirred for 40 minutes. 
Then DBU was added at room temperature, stirred 
for 1 hour quenched with a brine solution (5 mL) and 
separated with MTBE (3 x 5 mL). The combined 
organic extracts were dried over MgSO4 and 
concentrated in vacuo. Purification by flash 
chromatography on silica gave the oil 3.2 (0.025 g, 
56 %), as a 50:50 cis/trans mixture. 
Spectral data for the major diastereomer 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.86 (dd, J = 
8.4, 1.4 Hz, 2H), 7.53 – 7.46 (m, 1H), 7.40 (dd, J = 
8.3, 7.0 Hz, 2H), 7.21 (d, J = 8.6 Hz, 2H), 7.00 (dd, J 
= 15.6, 1.2 Hz, 1H), 6.90 (dd, J = 15.5, 5.6 Hz, 1H), 
6.82 (d, J = 8.6 Hz, 2H), 4.48 (d, J = 11.5 Hz, 1H), 
4.37 (d, J = 11.5 Hz, 1H), 4.20 – 4.11 (m, 1H), 3.73 
(s, 3H), 1.29 (d, J = 6.6 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 190.70, 159.29, 
149.65, 137.71, 132.92, 130.29, 129.29, 128.64, 






IR (ATR): 3376, 2974, 2930, 1735, 1701, 1699, 
1602, 1584, 1558, 1493, 1450, 1371, 1314, 1274, 
1174, 1109, 1069, 1025, 1001, 969, 936, 909, 850, 
805, 761, 732, 709, 698, 667 cm–1. 
A dried flask containing 3.2 (0.0222 g, 0.0749 mmol) 
and THF (1 mL) was cooled to 0 oC and a solution of 
methyl magnesium bromide was added dropwise 




oC for one hour before addition of BzCl (0.017 mL, 
0.15 mmol). The mixture was warmed to room 
temperature and stirred overnight. The crude mixture 
was quenched with saturated aq. NH4Cl (5 mL) and 
separated with DCM (3 x 5 mL). The combined 
organic extracts were dried over MgSO4 and 
concentrated in vacuo. The Crude reaction mixture 
was then subjected to the general procedure for DDQ 
removal of PMB protecting group. Purification by 
flash chromatography on silica gave the oil 3.3 
(0.0055 g, 25 %). 
 
Spectral data for the major diastereomer 
 
1H NMR (500 MHz, Chloroform-d) δ = 8.15 – 8.11 
(m, 2H), 8.10 – 8.06 (m, 2H), 7.66 – 7.60 (m, 1H), 
7.60 – 7.54 (m, 1H), 7.52 – 7.42 (m, 10H), 7.37 (ddd, 
J = 8.0, 6.3, 1.2 Hz, 2H), 7.31 – 7.26 (m, 2H), 6.26 
(dd, J = 15.7, 1.2 Hz, 2H), 5.90 (ddd, J = 15.8, 6.2, 
1.3 Hz, 2H), 4.44 (pdd, J = 6.3, 2.3, 1.3 Hz, 2H), 2.05 
(s, 3H), 2.04 (s, 3H), 1.35 (d, J = 6.4 Hz, 3H), 1.33 
(d, J = 6.1 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 171.21, 164.91, 
143.96, 134.36, 134.27, 133.71, 133.47, 133.40, 
132.88, 132.86, 131.32, 130.29, 130.20, 129.61, 
129.36, 128.71, 128.58, 128.49, 128.44, 128.38, 
128.31, 127.35, 126.01, 125.19, 125.15, 124.65, 






To an open air flask 2.9 (0.228 g, 0.735 mmol) and 
DCM (4 mL) was added and placed into a room temp 
water bath. To the flask, sodium bicarbonate (308 
mg, 3.67 mmol) and Dess-Martin periodinane (467 
mg, 1.10 mmol) was added. The solution was stirred 
at room temp for 1 hour. The reaction was washed 
with 1M NaOH (5mL) and extracted with MTBE (3 x 
5 mL). The combined organic extracts were dried 
over MgSO4, and concentrated in vacuo. Purification 
by flash chromatography on silica gave 2.14 (0.225 g, 
99%), as an oil. 
 
IR (ATR): 2935, 2858, 2197, 1666, 1611, 1585, 
1511, 1489, 1454, 1442, 1361, 1301, 1283, 1245, 
1172, 1059, 1033, 997, 907, 819, 757, 728, 688 cm–1. 
1H NMR (500 MHz, Chloroform-d) δ = 7.58 – 7.53 
(m, 2H), 7.51 – 7.45 (m, 1H), 7.44 – 7.35 (m, 2H), 
7.28 (d, J = 8.2 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 
4.51 (s, 2H), 3.83 (dd, J = 9.4, 7.0 Hz, 1H), 3.78 (s, 
3H), 3.65 (dd, J = 9.4, 5.5 Hz, 1H), 3.01 (pd, J = 7.0, 
5.5 Hz, 1H), 1.29 (d, J = 7.1 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 189.81, 159.19, 
133.10, 130.69, 130.08, 129.32, 128.60, 120.05, 








A Schlenk tube was charged with copper (I) iodide 
(0.209 g, 1.103 mmol) and THF (4 mL). The solution 
was cooled to -30 oC and a 1.6M solution of MeLi in 
ether was added dropwise. After stirring for 30 
minutes at -30 oC the solution was cooled to -78 oC 
and 2.14 (0.225 g, 0.731 mmol) was added dropwise 
turning the solution yellow. The reaction was left for 
1 hour at -78 oC, quenched with saturated aq. NH4Cl 
(5 mL) and separated with DCM (3 x 5 mL). ). The 
combined organic extracts were dried over MgSO4 
and concentrated in vacuo. Purification by flash 
chromatography on silica gave the oil 2.15 (0.143 g, 
60%), as a 50:50 cis/trans mixture. 
 
Spectral data for mixture of cis/trans isomers. 
 
IR (ATR): 2932, 2855, 1680, 1610, 1567, 1573, 
1511, 1492, 1442, 1360, 1301, 1244, 1172, 1084, 
1032, 965, 917, 818, 762, 697 cm–1 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.52 – 7.47 
(m, 2H), 7.40 (dd, J = 5.0, 1.9 Hz, 3H), 7.38 – 7.32 
(m, 3H), 7.30 – 7.20 (m, 6H), 6.89 (dd, J = 12.9, 8.7 
Hz, 4H), 6.60 (d, J = 1.4 Hz, 1H), 6.26 (d, J = 1.4 Hz, 
1H), 4.51 (d, J = 11.7 Hz, 1H), 4.47 (d, J = 11.7 Hz, 
1H), 4.42 (d, J = 11.6 Hz, 1H), 4.39 (d, J = 11.7 Hz, 
1H), 3.83 (s, 3H), 3.81 (s, 3H), 3.74 (dd, J = 9.3, 7.3 
Hz, 1H), 3.60 (dd, J = 9.2, 7.0 Hz, 1H), 3.52 (dd, J = 
9.2, 5.7 Hz, 1H), 3.39 (dd, J = 9.3, 6.1 Hz, 1H), 3.01 
(pd, J = 7.1, 5.7 Hz, 1H), 2.84 – 2.75 (m, 1H), 2.58 
(d, J = 1.3 Hz, 3H), 2.21 (d, J = 1.5 Hz, 3H), 1.18 (d, 
J = 7.1 Hz, 3H), 1.04 (d, J = 7.0 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 203.37, 203.04, 
159.18, 159.16, 154.42, 152.56, 142.70, 140.87, 
130.40, 130.35, 129.28, 129.24, 129.07, 128.54, 




113.77, 113.74, 72.94, 72.78, 72.06, 72.02, 55.29, 






To an open air flask 2.5 (0.165 g, 0.556 mmol) and 
DCM (3 mL) was added and placed into a room temp 
water bath. To the flask, sodium bicarbonate (223 
mg, 2.78 mmol) and Dess-Martin periodinane (353 
mg, 0.834 mmol) was added. The solution was stirred 
at room temp for 1 hour. The reaction was washed 
with 1M NaOH (5mL) and extracted with MTBE (3 x 
5 mL). The combined organic extracts were dried 
over MgSO4, and concentrated in vacuo. Purification 
by flash chromatography on silica gave 2.12 (0.0982 
g, 60 %), as an oil. 
 
IR (ATR): 2981, 2934, 2835, 2195, 1670, 1611, 
1585, 1511, 1489, 1463, 1442, 1392, 1367, 1301, 
1282, 1245, 1172, 1099, 1069, 1031, 996, 973, 846, 
821, 756, 688 cm–1. 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.66 – 7.56 
(m, 2H), 7.52 – 7.46 (m, 1H), 7.46 – 7.38 (m, 2H), 
7.38 – 7.33 (m, 2H), 6.89 (s, 2H), 4.73 (d, J = 11.2 
Hz, 1H), 4.50 (d, J = 11.2 Hz, 1H), 4.14 (q, J = 6.9 
Hz, 1H), 3.83 (s, 3H), 1.51 (d, J = 6.9 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 190.08, 159.45, 
133.30, 130.98, 129.70, 129.62, 128.67, 119.86, 







A Schlenk tube was charged with copper (I) iodide 
(0.095 g, 0.50 mmol) and THF (2 mL). The solution 
was cooled to -30 oC and a 1.6M solution of MeLi in 
ether was added dropwise. After stirring for 30 
minutes at -30 oC the solution was cooled to -78 oC 
and 2.12 (0.0982 g, 0.334 mmol) was added dropwise 
turning the solution yellow. The reaction was left for 
1 hour at -78 oC, quenched with saturated aq. NH4Cl 
(5 mL) and separated with DCM (3 x 5 mL). ). The 
combined organic extracts were dried over MgSO4 
and concentrated in vacuo. Purification by flash 
chromatography on silica gave the oil 2.13 (0.0858 g, 
83 %), as a 50:50 cis/trans mixture. 
 
Spectral data for mixture of cis/trans isomers. 
 
IR (ATR): 2932, 1687, 1610, 1596, 1573, 1512, 
1492, 1442, 1370, 1301, 1245, 1173, 1091, 1031, 
956, 910, 820, 760, 731, 696 cm–1. 
 
1H NMR (500 MHz, Chloroform-d) δ = 7.53 (dd, J = 
6.6, 3.0 Hz, 2H), 7.42 (q, J = 2.9 Hz, 3H), 7.36 (qd, J 
= 7.6, 6.4, 3.6 Hz, 3H), 7.31 – 7.25 (m, 4H), 7.23 – 
7.18 (m, 2H), 6.94 – 6.86 (m, 5H), 6.56 (d, J = 1.8 
Hz, 1H), 4.57 (d, J = 11.3 Hz, 1H), 4.52 (d, J = 11.2 
Hz, 1H), 4.46 (d, J = 11.4 Hz, 1H), 4.35 (d, J = 11.3 
Hz, 1H), 4.02 (q, J = 6.9 Hz, 1H), 3.85 (t, J = 7.2 Hz, 
1H), 3.83 (s, 3H), 3.82 (s, 3H), 2.63 – 2.60 (m, 3H), 
2.24 (d, J = 1.4 Hz, 3H), 1.40 (d, J = 6.9 Hz, 3H), 
1.33 (d, J = 6.9 Hz, 3H). 
 
13C NMR (126 MHz, CDCl3) δ = 203.14, 201.41, 
159.40, 156.73, 155.80, 142.52, 140.89, 129.95, 
129.88, 129.66, 129.58, 129.37, 128.59, 128.14, 
128.05, 126.98, 126.59, 121.22, 119.35, 113.91, 
113.89, 81.42, 80.42, 71.72, 71.53, 55.31, 53.48, 
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